<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="mco270032" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">MedComm (2020)</journal-id><journal-id journal-id-type="iso-abbrev">MedComm (2020)</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2688-2663</journal-id><journal-id journal-id-type="publisher-id">MCO2</journal-id><journal-title-group><journal-title>MedComm</journal-title></journal-title-group><issn pub-type="epub">2688-2663</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40013315</article-id><article-id pub-id-type="pmc">PMC11862887</article-id><article-id pub-id-type="doi">10.1002/mco2.70032</article-id><article-id pub-id-type="publisher-id">MCO270032</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Targeting WDPF domain of Hsp27 achieves a broad spectrum of antiviral</article-title><alt-title alt-title-type="left-running-head">WU <sc>et&#x000a0;al.</sc>
</alt-title></title-group><contrib-group><contrib id="mco270032-cr-0001" contrib-type="author"><name><surname>Wu</surname><given-names>Mandi</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1756-0103</contrib-id><xref rid="mco270032-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="mco270032-note-0001" ref-type="author-notes">
<sup>#</sup>
</xref></contrib><contrib id="mco270032-cr-0002" contrib-type="author"><name><surname>Li</surname><given-names>Wei</given-names></name><xref rid="mco270032-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="mco270032-note-0001" ref-type="author-notes">
<sup>#</sup>
</xref></contrib><contrib id="mco270032-cr-0003" contrib-type="author"><name><surname>Leung</surname><given-names>Houying</given-names></name><xref rid="mco270032-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mco270032-cr-0004" contrib-type="author"><name><surname>Wang</surname><given-names>Yiran</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4989-3893</contrib-id><xref rid="mco270032-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mco270032-cr-0005" contrib-type="author"><name><surname>Wan</surname><given-names>Qianya</given-names></name><xref rid="mco270032-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mco270032-cr-0006" contrib-type="author"><name><surname>Chen</surname><given-names>Peiran</given-names></name><xref rid="mco270032-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mco270032-cr-0007" contrib-type="author"><name><surname>Chen</surname><given-names>Cien</given-names></name><xref rid="mco270032-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mco270032-cr-0008" contrib-type="author"><name><surname>Li</surname><given-names>Yichen</given-names></name><xref rid="mco270032-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mco270032-cr-0009" contrib-type="author" corresp="yes"><name><surname>Yao</surname><given-names>Xi</given-names></name><xref rid="mco270032-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>mlhe7788@gmail.com</email><email>minglihe@cityu.edu.hk</email></address></contrib><contrib id="mco270032-cr-0010" contrib-type="author" corresp="yes"><name><surname>He</surname><given-names>Ming&#x02010;Liang</given-names></name><xref rid="mco270032-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="mco270032-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><address><email>xi.yao@cityu.edu.hk</email></address></contrib></contrib-group><aff id="mco270032-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Biomedical Sciences</named-content>
<institution>City University of Hong Kong</institution>
<institution>Hong Kong Special Administrative Region</institution>
<city>Hong Kong</city>
<country country="CN">China</country>
</aff><aff id="mco270032-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Weihai Municipal Hospital</named-content>
<named-content content-type="organisation-division">Cheeloo College of Medicine</named-content>
<institution>Shandong University</institution>
<city>Weihai</city>
<named-content content-type="country-part">Shandong</named-content>
<country country="CN">China</country>
</aff><aff id="mco270032-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>CityU Shenzhen Research Institute</institution>
<city>Nanshan</city>
<named-content content-type="country-part">Shenzhen</named-content>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Xi Yao and Ming&#x02010;Liang He, Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.<break/> Email: <email>mlhe7788@gmail.com</email>, <email>minglihe@cityu.edu.hk</email> and <email>xi.yao@cityu.edu.hk</email>
<break/>
</corresp><fn id="mco270032-note-0001" fn-type="equal"><label>#</label><p>Mandi Wu and Wei Li contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2025</year></pub-date><volume>6</volume><issue seq="250">3</issue><issue-id pub-id-type="doi">10.1002/mco2.v6.3</issue-id><elocation-id>e70032</elocation-id><history>
<date date-type="rev-recd"><day>03</day><month>11</month><year>2024</year></date>
<date date-type="received"><day>18</day><month>6</month><year>2024</year></date>
<date date-type="accepted"><day>14</day><month>11</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">MedComm</italic> published by Sichuan International Medical Exchange &#x00026; Promotion Association (SCIMEA) and John Wiley &#x00026; Sons Australia, Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:MCO2-6-e70032.pdf"/><abstract><title>Abstract</title><p>Enterovirus A71 (EV&#x02010;A71) is a positive&#x02010;sense single&#x02010;stranded RNA virus, which hijacks host proteins to benefit viral internal ribosome entry site (IRES)&#x02010;dependent protein translation and further propagation. We demonstrated that serine 78 (S78) phosphorylation of Hsp27 is critical for Hsp27/hnRNP A1 relocalization upon EV&#x02010;A71 infection. Here, we report that the deletion of WDPF and ACD domains disturbs subcellular localization of Hsp27, resulting in partial nuclear translocation. The domain deletion&#x02010;induced Hsp27 nuclear translocation fails to direct hnRNP A1 translocation. The 2A<sup>pro</sup>&#x02010;induced IRES activity and viral replication are suppressed by the deletion of WDPF or ACD domain. Surprisingly, a peptide (WDPF) dramatically inhibits S78 phosphorylation. Therefore, hnRNP A1 translocation, viral IRES activity, and viral protein translation and propagation are all strongly suppressed by the WDPF peptide, but not by peptide without WDPFR sequence (&#x00394;WDPF). Moreover, the WDPF peptide also has potent antiviral activity on other RNA virus (e.g., coronavirus HCoV&#x02010;OC43) and DNA virus (e.g., HSV&#x02010;1 and HBV). Peptide treatment with kinase inhibitor Sorafenib brings an additional inhibitory effect on HCoV&#x02010;OC43 and HSV&#x02010;1. Taken together, we uncover a crucial role of WDPF domain in S78 phosphorylation for EV&#x02010;A71&#x02010;induced hnRNP A1 nuclear translocation, IRES&#x02010;dependent viral protein translation, and EV&#x02010;A71 propagation. Our results explore a new path for target&#x02010;based pan&#x02010;antiviral strategy.</p></abstract><abstract id="mco270032-abs-0001" abstract-type="graphical"><p>Ser78 phosphorylation of Hsp27 plays an important role in Hsp27 nuclear translocation, which induces hnRNP A1 cytosol relocation and further enhances the IRES activity and viral replication mediated by EV&#x02010;A71 2A<sup>pro</sup>. Hsp27&#x02010;derived WDPF peptide competitively inhibited Hsp27 phosphorylation on serine 78 to block Hsp27/hnRNP A1 translocation and further IRES&#x02010;dependent viral reproduction. 
<boxed-text position="anchor" content-type="graphic"><graphic xlink:href="MCO2-6-e70032-g005.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="mco270032-kwd-0001">antiviral</kwd><kwd id="mco270032-kwd-0002">hnRNP A1 translocation</kwd><kwd id="mco270032-kwd-0003">Hsp27</kwd><kwd id="mco270032-kwd-0004">phosphorylation</kwd><kwd id="mco270032-kwd-0005">WDPF domain</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>RGC General Research Fund of Hong Kong Special Administrative Region</funding-source><award-id>11104020</award-id></award-group><award-group id="funding-0002"><funding-source>Strategic funds from City University of Hong Kong</funding-source><award-id>#7005874</award-id><award-id>#7020032</award-id><award-id>#9680149</award-id></award-group></funding-group><counts><fig-count count="7"/><table-count count="0"/><page-count count="19"/><word-count count="9757"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:26.02.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="mco270032-cit-0075">
<string-name>
<surname>Wu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Targeting WDPF domain of Hsp27 achieves a broad spectrum of antiviral</article-title>. <source>MedComm</source>. <year>2025</year>;<volume>6</volume>:<elocation-id>e70032</elocation-id>. <pub-id pub-id-type="doi">10.1002/mco2.70032</pub-id>
</mixed-citation>
</p></notes></front><body><sec id="mco270032-sec-0010"><label>1</label><title>INTRODUCTION</title><p>Enterovirus A71 (EV&#x02010;A71) is a positive&#x02010;sense single&#x02010;stranded RNA virus [(+) ssRNA)] in the Picornavirus family. EV&#x02010;A71 infection can cause hand, foot, and mouth disease (HFMD) in children under 5 years old.<xref rid="mco270032-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="mco270032-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Although HFMD is self&#x02010;limiting and mild in most cases, a small portion of patients suffers from fatal neurological diseases, including aseptic meningitis, rhombencephalitis, acute flaccid paralysis, and brainstem encephalitis.<xref rid="mco270032-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="mco270032-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> In recent years, large&#x02010;scale outbreaks of EV&#x02010;A71&#x02010;caused HFMD cases have been reported in China, Vietnam, South Korea, Russia, and Singapore.<xref rid="mco270032-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="mco270032-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> In China, an EV&#x02010;A71 C4&#x02010;genotype&#x02010;based vaccine is the only licensed vaccine in the world.<xref rid="mco270032-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="mco270032-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="mco270032-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="mco270032-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> However, supportive therapy remains the primary treatment, as there are no approved effective antiviral drugs for EV&#x02010;A71 infection.<xref rid="mco270032-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="mco270032-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>
</p><p>The EV&#x02010;A71 genome encodes an open reading frame for a polyprotein, which is proteolytically cleaved into four structural proteins and seven nonstructural proteins.<xref rid="mco270032-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="mco270032-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> The four structural proteins, VP1, VP2, VP3, and VP4, assemble to form the viral capsid, which is responsible for viral receptor binding, entry, stability, and assembly.<xref rid="mco270032-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Nonstructural proteins are 2A<sup>pro</sup>, 2B, 2C, 3A, 3B (also known as VPg), 3C<sup>pro</sup>, and 3D<sup>pol</sup>, which are associated with viral uncoating, protein processing, RNA replication, and immune evasion.<xref rid="mco270032-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="mco270032-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="mco270032-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="mco270032-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="mco270032-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> For example, the 2A protease (2A<sup>pro</sup>) cleaves the newly synthesized viral polyprotein into functional proteins, suppresses host cap&#x02010;dependent translation, and induces internal ribosome entry site (IRES)&#x02010;dependent translation.<xref rid="mco270032-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="mco270032-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>
</p><p>To initiate the polyprotein translation, EV&#x02010;A71 utilizes an IRES element, located in 5&#x02032;UTR, in a cap&#x02010;independent manner, with the help of host IRES&#x02010;specific transacting factors (ITAFs). ITAFs bind to the IRES elements to promote the ribosome recruitment. Numerals ITAFs are involved in regulating EV&#x02010;A71 infection, such as far&#x02010;upstream&#x02010;element binding protein 1 (FBP1), FBP2, heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1), hnRNP K, and poly(rC)&#x02010;binding protein 1 (PCBP1).<xref rid="mco270032-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> FBP1 facilitates EV&#x02010;A71 IRES activity, while FBP2 has an opposite, negative impact.<xref rid="mco270032-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="mco270032-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> hnRNP K plays an essential role in viral protein synthesis.<xref rid="mco270032-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> hnRNP A1 changes the conformation of IRES element to direct the initiation of viral translation.<xref rid="mco270032-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="mco270032-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> The virus&#x02010;induced relocalization of hnRNP A1 has been reported to benefit viral infection in cytoplasm, which is further promoted by Rhinovirus 2A<sup>pro</sup> and 3C<sup>pro</sup>.<xref rid="mco270032-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> We previously reported that EV&#x02010;A71 hijacks heat shock protein 27 (Hsp27) to induce hnRNP A1 cytosolic translocation.<xref rid="mco270032-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> Recently, we further demonstrated that serine 78 (S78) phosphorylation of Hsp27 is critical for EV&#x02010;A71&#x02010; or 2A<sup>pro</sup>&#x02010;induced hnRNP A1 cytosolic translocation and IRES&#x02010;dependent viral protein translation.<xref rid="mco270032-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>
</p><p>Hsp27, a chaperone protein, functions under various stimuli, including high temperature, chemical treatment, UV, radiation, and pathogen infections. Hsp27 exists as monomers, dimers, and oligomers in cells, which are regulated by the phosphorylation at serine 15, 78, 82 upon signal transductions.<xref rid="mco270032-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> Phosphorylation of Hsp27 is induced by mitogen&#x02010;activated protein kinases associated protein kinases (MAPKAP kinase 2, MK2), a downstream factor of MAP p38 protein kinase.<xref rid="mco270032-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="mco270032-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> Hsp27 normally locates in cytoplasm, while phosphorylated Hsp27 is present in both cytoplasm and nucleus to respond to different stimuli.<xref rid="mco270032-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>, <xref rid="mco270032-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> Hsp27 is composed of a highly conserved &#x003b1; crystalline domain (ACD) domain, flanked by an N&#x02010;terminal WDPF domain and a flexible C&#x02010;terminal domain. The less conserved WDPF domain is associated with the chaperone activity of Hsp27.<xref rid="mco270032-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> The flexible C&#x02010;terminal domain is involved in the regulation of protein interactions and oligomer solubility.<xref rid="mco270032-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> The WDPF domain and C&#x02010;terminal domain can both interact with the ACD domain, changing the conformation to generate and stabilize oligomers by regulating the S78 and S82 phosphorylation.<xref rid="mco270032-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref>, <xref rid="mco270032-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>, <xref rid="mco270032-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref>, <xref rid="mco270032-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> Here, we report that WDPF domain plays a crucial role in S78 phosphorylation, and a peptide derived from the WDPF domain dramatically inhibits S78 phosphorylation and viral propagation in a dose&#x02010;dependent manner, paving the way for the development of effective EV&#x02010;A71 antivirals.</p></sec><sec id="mco270032-sec-0020"><label>2</label><title>RESULTS</title><sec id="mco270032-sec-0030"><label>2.1</label><title>Critical roles of WDPF and ACD domains in Hsp27 cellular localization</title><p>To explore the important domains governing EV&#x02010;A71&#x02010;induced Hsp27 translocation, we generated a series of Hsp27 truncation mutants by deleting one or two functional domains, including the ACD, the WDPF domain, and the flexible region (Flex) (Figure&#x000a0;<xref rid="mco270032-fig-0001" ref-type="fig">1A</xref>). We stably expressed these Hsp27&#x02013;eGFP fusion constructs in Hsp27 knockout (Hsp27&#x02013;KO) RD cells using lentiviral transduction.<xref rid="mco270032-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> The cells were infected with EV&#x02010;A71 at MOI 40 for 6&#x000a0;h. However, the protein expression levels of Hsp27 with ACD deletion (Hsp27&#x02206;ACD, Hsp27&#x02206;ACD/&#x02206;WDPF, and Hsp27&#x02206;ACD/&#x02206;Flex) are hardly detected by western blot in Hsp27&#x02013;KO cells (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S1</xref>), suggesting a critical role of the ACD domain in Hsp27 protein stabilization. The nuclear localization of Hsp27 and its mutants was observed and captured under confocal microscopy. As shown in Figure&#x000a0;<xref rid="mco270032-fig-0001" ref-type="fig">1B</xref>, Hsp27 and Hsp27&#x02206;Flex naturally localizes in the cytosol; Hsp27&#x02206;ACD shows certain nuclear localization and mostly cytosol localization, while WDFP deletion ensures a large portion of Hsp27 localizing in nuclei without EV&#x02010;A71 infection, indicating that WDFP domain (<sup>16</sup>WDPFRDWYPH<sup>25</sup>) plays an inhibitory role in Hsp27 nuclear localization. Alternatively, deletion of WDFP may generate an unknown, nonspecific nuclear localization signal (NLS). Consistently, simultaneous deleting WDFP domain with either ACD domain or Flex domain ensures Hsp27 to localize in both cytoplasm and nucleus; whereas less amount of Hsp27 protein is in the nucleus when the ACD and Flex regions were both deleted. Quantitative colocalization analysis revealed that the deletion of the ACD and WDPF domains significantly increased the Manders&#x02019; colocalization coefficient M1 between Hsp27 and the nuclear marker Hoechst, suggesting enhanced Hsp27 nuclear redistribution (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S2A</xref>). Upon EV&#x02010;A71 infection, wild&#x02010;type Hsp27 and all the truncation mutants exhibited similar patterns of nuclear translocation (Figures&#x000a0;<xref rid="mco270032-fig-0001" ref-type="fig">1C</xref> and <xref rid="mco270032-supinfo-0001" ref-type="">S2A</xref>). These demonstrated an important role of ACD domain and WDPF domains in Hsp27 subcellular localization.</p><fig position="float" fig-type="FIGURE" id="mco270032-fig-0001"><label>FIGURE 1</label><caption><p>Blockage of hnRNP A1 nuclear translocation by WDPF domain and ACD domain truncation of Hsp27 upon EV&#x02010;A71 infection. (A) Diagram of Hsp27&#x02013;eGFP and domain deletion constructs. Yellow, conserved &#x003b1;&#x02010;crystallin domain; blue, WDPF&#x02010;domain; orange zigzag line, flexible C&#x02010;terminal sequence; purple line, linker; green, eGFP; pink, Flag. The residue positions are indicated above the diagram. (B and C) Hsp27&#x02013;KO cells were coinfected with Lenti&#x02013;hnRNPA1&#x02013;mCherry and Lenti&#x02013;Hsp27&#x02013;WT&#x02013;eGFP&#x02013;Flag (or Lenti&#x02013;Hsp27&#x02013;&#x00394;ACD&#x02013;eGFP&#x02013;Flag, Lenti&#x02013;Hsp27&#x02013;&#x00394;WDPF&#x02013;eGFP&#x02013;Flag, Lenti&#x02013;Hsp27&#x02013;&#x00394;Flex&#x02013;eGFP&#x02013;Flag, Lenti&#x02013;Hsp27&#x02013;&#x00394;ACD/&#x02206;WDPF&#x02013;eGFP&#x02013;Flag, Lenti&#x02013;Hsp27&#x02013;&#x00394;ACD/&#x02206;Flex&#x02013;eGFP&#x02013;Flag, Lenti&#x02013;Hsp27&#x02013;&#x00394;WDPF/&#x02206;Flex&#x02013;eGFP&#x02013;Flag) for 3 days, then infected with or without EV&#x02010;A71 at the MOI of 40 for 6&#x000a0;h. The cells were fix and the nuclei were stained with Hoechst (blue). The images were captured by Nikon A1HD25 Confocal Microscope. For Hsp27, cells with nuclear translocation were marked by white arrows. For hnRNP A1, cells with cytosol translocation were marked by white arrows. The scale bar is 10&#x000a0;&#x000b5;M.</p></caption><graphic xlink:href="MCO2-6-e70032-g004" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="mco270032-sec-0040"><label>2.2</label><title>Essential role of WDPF and ACD domains in hnRNP A1 translocation upon EV&#x02010;A71 infection</title><p>hnRNP A1&#x02013;mCherry fusion protein was coexpressed in Hsp27&#x02013;KO cells with the restoration of wild&#x02010;type or mutant Hsp27 constructs using lentiviral vectors to examine their subcellular localization. As expected, without any stimuli, hnRNP A1 did not translocate into cytoplasm when coexpressed with wild&#x02010;type Hsp27 or Hsp27 mutants lacking the ACD domain (Hsp27WT, Hsp27&#x02206;ACD, Hsp27&#x02206;ACD/Flex) (Figure&#x000a0;<xref rid="mco270032-fig-0001" ref-type="fig">1B</xref>). Surprisingly, hnRNP A1 did not redistribute to the cytosol even though Hsp27 translocated into the nucleus when WDPF domain was deleted (Figure&#x000a0;<xref rid="mco270032-fig-0001" ref-type="fig">1B</xref>; images from Hsp27&#x02206;WDFP, Hsp27&#x02206;ACD/&#x02206;WDFP, Hsp27&#x02206;WDFP/&#x02206;Flex), indicating that the nuclear Hsp27&#x02206;WDFP is not sufficient to induce the cytosolic redistribution of hnRNP A1.</p><p>Furthermore, the cells were infected with EV&#x02010;A71 at the MOI of 40 for 6&#x000a0;h to capture the subcellular localization of Hsp27 (or its domain&#x02010;deleted mutants) and hnRNP A1. The colocalization of hnRNP A1 and Hoechst was also quantified. Deletion of Flex region did not affect the cytosolic redistribution of hnRNP A1 (Figures&#x000a0;<xref rid="mco270032-fig-0001" ref-type="fig">1C</xref> and <xref rid="mco270032-supinfo-0001" ref-type="">S2B</xref>; Hsp27&#x02206;Flex), indicating that the cytosolic translocation of hnRNP A1 is independent of the Flex of Hsp27. Importantly, the cytosol redistribution of hnRNPA1 was blocked by the deletion of the ACD domain of Hsp27 (Figures&#x000a0;<xref rid="mco270032-fig-0001" ref-type="fig">1C</xref> and <xref rid="mco270032-supinfo-0001" ref-type="">S2B</xref>; Hsp27&#x02206;ACD). The absence of WDPF domain abolished the cytoplasmic translocation of hnRNP A1 completely, even though more Hsp27&#x02206;WDFP mutant translocated into the nucleus upon EV&#x02010;A71 infection (Figures&#x000a0;<xref rid="mco270032-fig-0001" ref-type="fig">1C</xref> and <xref rid="mco270032-supinfo-0001" ref-type="">S2B</xref>; Hsp27&#x02206;WDFP). Consistently, the simultaneous deletion of two domains of Hsp27 blocked the translocation of hnRNP A1 (Figures&#x000a0;<xref rid="mco270032-fig-0001" ref-type="fig">1C</xref> and <xref rid="mco270032-supinfo-0001" ref-type="">S2B</xref>; Hsp27&#x02206;ACD/&#x02206;WDPF, Hsp27&#x02206;ACD/&#x02206;Flex, Hsp27&#x02206;WDPF/&#x02206;Flex). Collectively, both ACD and WDPF domains are essential to EV&#x02010;A71&#x02010;induced cytosol hnRNPA1 translocation for IRES&#x02010;dependent translation.</p><p>The 2A<sup>pro</sup>&#x02010;induced Hsp27/hnRNP A1 relocalization was also examined. Consistent with EV&#x02010;A71 infection, after 2A<sup>pro</sup> transfection, Hsp27 and its mutants localized both in nucleus and cytoplasm (Figures&#x000a0;<xref rid="mco270032-fig-0002" ref-type="fig">2A</xref> and <xref rid="mco270032-supinfo-0001" ref-type="">S2C</xref>). However, the translocation of hnRNP A1 was blocked by the deletion of WDPF domain or ACD domain (Figures&#x000a0;<xref rid="mco270032-fig-0002" ref-type="fig">2A</xref> and <xref rid="mco270032-supinfo-0001" ref-type="">S2D</xref>). Importantly, consistent with previous results, the translocation of Hsp27/hnRNP A1 was dependent on the protease activity as the inactive 2A<sup>pro</sup> mutant (2A<sup>C110A</sup>) failed to direct the relocalization of Hsp27 or hnRNP A1 in the presence of Hsp27 or its Hsp27 mutants (Figures&#x000a0;<xref rid="mco270032-fig-0002" ref-type="fig">2B</xref> and <xref rid="mco270032-supinfo-0001" ref-type="">S2C,D</xref>).</p><fig position="float" fig-type="FIGURE" id="mco270032-fig-0002"><label>FIGURE 2</label><caption><p>Inhibition of 2A<sup>pro</sup>&#x02010;induced hnRNP A1 redistribution and viral IRES&#x02010;dependent translation by ACD and WDPF domains truncation. (A and B) Hsp27&#x02013;KO RD cells on the coverslips were coinfected with Lenti&#x02013;hnRNPA1&#x02013;mCherry and Lenti&#x02013;Hsp27&#x02013;WT&#x02013;eGFP (or Lenti&#x02013;Hsp27&#x02013;&#x00394;ACD&#x02013;eGFP, Lenti&#x02013;Hsp27&#x02013; &#x00394;WDPF&#x02013;eGFP, Lenti&#x02013;Hsp27&#x02013;&#x00394;Flex&#x02013;eGFP, Lenti&#x02013;Hsp27&#x02013;&#x00394;ACD/&#x02206;WDPF&#x02013;eGFP, Lenti&#x02013;Hsp27&#x02013; &#x00394;ACD/&#x02206;Flex&#x02013;eGFP, Lenti&#x02013;Hsp27&#x02013;&#x00394;WDPF/&#x02206;Flex&#x02013;eGFP) at the MOI of 20 for 3 days, then transfected with 2A<sup>pro</sup> or 2A<sup>C110A</sup> plasmids (500&#x000a0;ng) for 24&#x000a0;h. The cells were fixed, and the nuclei were stained with Hoechst (Blue). The images were captured by Nikon A1HD25 Confocal Microscope. For Hsp27, cells with nuclear translocation were marked by white arrows. For hnRNP A1, cells with cytosol translocation were marked by white arrows. The scale bar is 10&#x000a0;&#x000b5;M. (C) HEK293T cells were cotransfected with Hsp27 plasmids (WT, Hsp27&#x02013;&#x00394;ACD, Hsp27&#x02013;&#x00394;WDPF, Hsp27&#x02013;&#x00394;Flex, Hsp27&#x02013;&#x00394;ACD/&#x02206;WDPF, Hsp27&#x02013;&#x00394;ACD&#x02206;/Flex, Hsp27&#x02013;&#x00394;WDPF/&#x02206;Flex) plasmid (800&#x000a0;ng), 2A<sup>pro</sup> or 2A<sup>C110A</sup>&#x02010;expressing plasmid (200&#x000a0;ng) and pIRES reporter plasmid (200&#x000a0;ng) for 24&#x000a0;h, then the luciferase activity was measured. (D) Hsp27&#x02013;KO RD cells were infected with lentiviral vectors carrying Hsp27 WT and its truncations for 3 days, then infected with EV&#x02010;A71 at the MOI of 1 for 9&#x000a0;h. Intracellular viral RNA was extracted and quantified by qPCR. Statistical analyses were carried out using Student's <italic toggle="yes">t</italic>&#x02010;test. Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD.</p></caption><graphic xlink:href="MCO2-6-e70032-g006" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="mco270032-sec-0050"><label>2.3</label><title>Critical role of WDPF and ACD domains in IRES&#x02010;dependent translation and viral propagation</title><p>We further investigated the effect of three domains on 2A<sup>pro</sup>&#x02010;induced IRES activity. We cotransfected HEK293T cells with Hsp27 and its mutants, 2A<sup>pro</sup>&#x02010;expressing, and an IRES&#x02010;driven dicistronic reporter plasmids for 24&#x000a0;h. The renilla luciferase (Rluc) and firefly luciferase (Fluc) activities were measured using a dual&#x02010;luciferase assay kit. The normalized ratio of Fluc to Rluc represented the relative IRES activity. 2A<sup>pro</sup> increased the IRES activity by approximately 10 folds (Figure&#x000a0;<xref rid="mco270032-fig-0002" ref-type="fig">2C</xref>). In HEK293T cells, Hsp27&#x02013;WT and Hsp27&#x02206;Flex increased IRES activity by 30% (Figure&#x000a0;<xref rid="mco270032-fig-0002" ref-type="fig">2C</xref>). However, both Hsp27&#x02206;WDPF and Hsp27&#x02206;ACD failed to enhance the IRES activity. Consistently, all Hsp27 mutants with the deletion of two domains had no effect on viral IRES activity, likely due to the unalterable hnRNP A1 localization. As expected, 2A<sup>C110A</sup> had no effect on the viral IRES activity, consistent with our previous results (Figure&#x000a0;<xref rid="mco270032-fig-0002" ref-type="fig">2C</xref>).</p><p>To further investigate the effect of Hsp27 domain truncations on EV&#x02010;A71 replication, we measured the intracellular EV&#x02010;A71 RNA level 9&#x000a0;h post infection. The truncation of WDPF domain dramatically decreased the viral RNA by 57% (Figure&#x000a0;<xref rid="mco270032-fig-0002" ref-type="fig">2D</xref>). In Hsp27&#x02206;ACD expressing cells, viral RNA was significantly reduced by 39% (Figure&#x000a0;<xref rid="mco270032-fig-0002" ref-type="fig">2D</xref>). However, Hsp27&#x02206;Flex only mildly reduced the viral RNA level. In cells expressing Hsp27 mutants with two&#x02010;domain deletions, the viral RNA level was decreased due to the absence of WDPF or ACD domains (Figure&#x000a0;<xref rid="mco270032-fig-0002" ref-type="fig">2D</xref>), indicating the critical role of WDPF and ACD domains in IRES&#x02010;mediated translation during EV&#x02010;A71 infection.</p></sec><sec id="mco270032-sec-0060"><label>2.4</label><title>Blocking Hsp27/hnRNP A1 translocation by WDPF peptide</title><p>We postulated that targeting WDPF domain may block Hsp27/hnRNP A1 translocation and thereby inhibit viral propagation. We then designed a peptide, named WDPF, which comprises residues 16&#x02013;27 of Hsp27 and a TAT&#x02010;tag sequence for membrane penetration (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S3A</xref>). It was hypothesized that WDPF would be able to abrogate the WPDF function of endogenous Hsp27, while the controlled peptide, &#x00394;WDPF, without the consensus residues, would have less effect on Hsp27 function. The CC<sub>50</sub> (50% cytotoxic concentration) of the WDPF and &#x00394;WDPF peptides were 122&#x000a0;&#x000b5;M, and over 600&#x000a0;&#x000b5;M, respectively (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S3B,C</xref>). After pretreatment with the peptides for 2&#x000a0;h, RD cells were infected with or without EV&#x02010;A71 at the MOI of 40 for 6&#x000a0;h to investigate the localization of Hsp27 and hnRNP A1. Without EV&#x02010;A71 infection, the localization of Hsp27 and hnRNP A1 was not affected by peptide treatment (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S4A</xref>). In RD cells, EV&#x02010;A71 infection induced the nuclear translocation of Hsp27 and the cytosol translocation of hnRNP A1 (Figure&#x000a0;<xref rid="mco270032-fig-0003" ref-type="fig">3A</xref>). Notably, WDPF significantly inhibited the translocation of both Hsp27 and hnRNP A1, while peptide &#x00394;WDPF failed to do so (Figure&#x000a0;<xref rid="mco270032-fig-0003" ref-type="fig">3A&#x02013;C</xref>).</p><fig position="float" fig-type="FIGURE" id="mco270032-fig-0003"><label>FIGURE 3</label><caption><p>Blockage of Hsp27/hnRNP A1 relocalization and viral IRES activity by WDPF via inhibition of Hsp27 phosphorylation. (A) RD cells on the coverslips were treated with peptides (WDPF and &#x00394;WDPF) at the concentration of 25&#x000a0;&#x000b5;&#x0039c; for 2&#x000a0;h, and then infected with EV&#x02010;A71 at the MOI of 40 for 6&#x000a0;h. The cells were fixed and stained with anti&#x02010;Hsp27 (green) and anti&#x02010;hnRNP A1 (red), followed by Alexa Fluor 488&#x02010;conjugated anti&#x02010;rabbit antibody and Alexa Fluor 594&#x02010;conjugated anti&#x02010;mouse antibody. The nuclei were stained with Hoechst (Blue). The images were captured by Nikon A1HD25 Confocal Microscope. For Hsp27, cells with nuclear translocation were marked by white arrows. For hnRNP A1, cells with cytosol translocation were marked by white arrows. The scale bar is 20&#x000a0;&#x000b5;M. (B and C) The JACoP&#x02010;plugin of the extended&#x000a0;ImageJ&#x000a0;version&#x000a0;Fiji was used to compute the M1 colocalization coefficient (the fraction of Hsp27 in Hoechst or the fraction of hnRNP A1 in Hoechst). (D) HEK 293T cells were pretreated with peptides WDPF or &#x00394;WDPF at the concentration of 25&#x000a0;&#x000b5;&#x0039c; for 2&#x000a0;h and then cotransfected with Hsp27&#x02013;WT plasmid (800&#x000a0;ng), pIRES reporter plasmid (200&#x000a0;ng) and 2A<sup>pro</sup>&#x02010;expressing plasmid or 2A<sup>C110A</sup>&#x02010;expressing plasmid (200&#x000a0;ng) for 24&#x000a0;h, then the luciferase activity was measured. (E) RD cells were pretreated with peptides WDPF or &#x00394;WDPF for 2&#x000a0;h and infected with EV&#x02010;A71 at the MOI of 10 for 6&#x000a0;h. Cell lysates were collected for western blot assay. Hsp27 phosphorylation on S15, S78, and S82 were detected by specific antibodies. &#x003b2;&#x02010;Actin were detected as internal control. (F) Densitometric analysis of Figure&#x000a0;<xref rid="mco270032-fig-0003" ref-type="fig">3E</xref>. Statistical analyses were carried out using Student's <italic toggle="yes">t</italic>&#x02010;test. Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD.</p></caption><graphic xlink:href="MCO2-6-e70032-g007" position="anchor" id="jats-graphic-7"/></fig><p>The effect of the WDPF and &#x00394;WDPF peptides on 2A<sup>pro</sup>&#x02010;induced Hsp27/hnRNP A1 translocation was also examined. After 2&#x02010;h pretreatment with the peptides, RD cells were transfected with 2A<sup>pro</sup> or 2A<sup>C110A</sup> for 24&#x000a0;h. As expected, 2A<sup>pro</sup> successfully induced Hsp27/hnRNP A1 translocation (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S3D</xref>), while 2A<sup>C110A</sup> failed to do so (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S4B</xref>). Consistent with EV&#x02010;A7&#x02010;induced translocation, WDPF also blocked the 2A<sup>pro</sup>&#x02010;induced translocation of Hsp27 and hnRNP A1 to the basal level, as shown by the quantitative results (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S3E,F</xref>). In contrast, peptide &#x00394;WDPF treatment did not impede the induction of both Hsp27 nuclear translocation and hnRNP A1 cytosol translocation. Taken together, WDPF effectively inhibited Hsp27/hnRNP A1 translocation which induced by either EV&#x02010;A71 infection or 2A<sup>pro</sup> transfection.</p></sec><sec id="mco270032-sec-0070"><label>2.5</label><title>Inhibitory effects of WDPF peptide on S78 phosphorylation of Hsp27 and viral IRES activity</title><p>We have previously demonstrated that the phosphorylation of Hsp27 at S78 plays an essential role in the Hsp27/hnRNP A1 translocation and viral IRES&#x02010;dependent translation.<xref rid="mco270032-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> Clouser et&#x000a0;al.<xref rid="mco270032-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> reported that the WDPF domain and S15 are in the vicinity of S78 and S82 in space. We hypothesized that the inhibitory effect of WDPF on Hsp27/hnRNP A1 translocation may be associated with S78 phosphorylation. To examine this, we investigated the phosphorylation status of Hsp27 at each phosphorylation site upon EV&#x02010;A71 infection. Interestingly, WDPF, but not &#x00394;WDPF, inhibited the phosphorylation of Hsp27 dramatically at S78 in a dose&#x02010;dependent manner (Figure&#x000a0;<xref rid="mco270032-fig-0003" ref-type="fig">3E</xref>). Quantification of the data showed that the phosphorylation level at S78 was reduced by 75% with 50&#x000a0;&#x000b5;M&#x02010;WDPF treatment (Figure&#x000a0;<xref rid="mco270032-fig-0003" ref-type="fig">3F</xref>). The phosphorylation level of S15 and S82 were only mildly inhibited by 50&#x000a0;&#x000b5;M&#x02010;WDPF treatment (Figure&#x000a0;<xref rid="mco270032-fig-0003" ref-type="fig">3E</xref>). Furthermore, we examined the effect of peptides on the 2A<sup>pro</sup>&#x02010;induced IRES activity. WDPF decreased the 2A<sup>pro</sup>&#x02010;induced IRES activity by around 30%, which is a more substantial reduction compared with the &#x00394;WDPF peptide (Figure&#x000a0;<xref rid="mco270032-fig-0003" ref-type="fig">3D</xref>). Taken together, WDPF specifically inhibited S78 phosphorylation of Hsp27, which in turn hampered the Hsp27/hnRNP A1 translocation and viral IRES activity.</p></sec><sec id="mco270032-sec-0080"><label>2.6</label><title>Inhibitory effects of WDPF peptide on EV&#x02010;A71 propagation</title><p>To further investigate the potential antiviral effects of WDPF on EV&#x02010;A71 infection, we conducted a cytopathic effects (CPE) assay. In the control group, EV&#x02010;A71 infection induced severe CPE at the MOI of 1 for 12&#x000a0;h. We found that the WDPF peptide, but not &#x00394;WDPF, effectively protected the cells from EV&#x02010;A71&#x02010;induced CPE (Figure&#x000a0;<xref rid="mco270032-fig-0004" ref-type="fig">4C</xref>). Western blot experiments revealed that the WDPF peptide dramatically reduced the VP1 protein level of EV&#x02010;A71 in a dose&#x02010;dependent manner, while peptide &#x00394;WDPF had no effect on VP1 level (Figure&#x000a0;<xref rid="mco270032-fig-0004" ref-type="fig">4D,E</xref>). Consistently, the WDPF peptide but not &#x00394;WDPF, reduced the viral RNA level in a dose&#x02010;dependent manner (Figure&#x000a0;<xref rid="mco270032-fig-0004" ref-type="fig">4A,B</xref>). Specifically, the WDPF treatment decreased the viral RNA level by 65% at 25&#x000a0;&#x000b5;M and reduced the extracellular viral RNA level by 98% (Figure&#x000a0;<xref rid="mco270032-fig-0004" ref-type="fig">4F</xref>). More strikingly, WDPF treatment achieved over a 450&#x02010;fold reduction in virus yield, while peptide &#x00394;WDPF only decreased the viral titer by 40 folds (Figure&#x000a0;<xref rid="mco270032-fig-0004" ref-type="fig">4G</xref>). Taken together, WDPF displayed a potent antiviral effect against EV&#x02010;A71 infection with high specificity.</p><fig position="float" fig-type="FIGURE" id="mco270032-fig-0004"><label>FIGURE 4</label><caption><p>Inhibition of EV&#x02010;A71 replication and propagation by WDPF. (A and B) RD cells were treated with peptides WDPF or &#x00394;WDPF and then infected with EV&#x02010;A71 at the MOI of 1 for 9&#x000a0;h. Intracellular viral RNA was extracted and quantified by qPCR. The EC<sub>50</sub> of the WDPF peptide is 7.96&#x000a0;&#x000b5;M. (C) RD cells were treated with peptides and then infected with EV&#x02010;A71 at the MOI of 1 for 12&#x000a0;h. The EV&#x02010;A71&#x02010;induced CPE was captured. (D and E) EV&#x02010;A71 VP1 were detected. (F) RD cells were treated with peptides WDPF or &#x00394;WDPF and then infected with EV&#x02010;A71 at the MOI of 1 for 12&#x000a0;h. Extracellular viral RNA was extracted and quantified by qPCR. (G) Viral titration was calculated by TCID<sub>50</sub>. Statistical analyses were carried out using Student's <italic toggle="yes">t</italic>&#x02010;test. Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD.</p></caption><graphic xlink:href="MCO2-6-e70032-g002" position="anchor" id="jats-graphic-9"/></fig><p>To explore the potential effects of WDPF on viral entry, RD cells were pretreated with the WDPF peptide or &#x00394;WDPF for 2&#x000a0;h and then infected with EV&#x02010;A71 for 1&#x000a0;h (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S5A</xref>). The cytosolic viral RNA levels were not affected by the peptide treatment, indicating that WDPF and &#x00394;WDPF peptides have no effect on the entry of EV&#x02010;A71 (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S5B,C</xref>).</p><p>Furthermore, RD cells were infected with EV&#x02010;A71 for 1&#x000a0;h and then treated with the WDPF peptide or &#x00394;WDPF to assess the effect on postentry viral replication (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S6A</xref>). Importantly, the cytosolic viral RNA was reduced in a dose&#x02010;dependent manner by WDPF, but not by &#x00394;WDPF (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S6B,C</xref>). The half&#x02010;maximal effective concentration (EC<sub>50</sub>) of the WDPF peptide was 29.11&#x000a0;&#x000b5;M (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S6D</xref>). The viral protein VP1 level also showed a dose&#x02010;dependent reduction by the WDPF peptide, but not by &#x00394;WDPF (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S6E</xref>). On the contrary, a peptide NT&#x02010;WDPF without the TAT sequence has no effect on EV&#x02010;A71 RNA level or protein level (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S7A,B,D</xref>), indicating that the WDPF peptide functions intracellularly without affecting viral entry.</p><p>Furthermore, Hsp27&#x02013;WT or Hsp27&#x02013;S78A was expressed in Hsp27 KO cells. The peptide WDPF significantly decreased EV&#x02010;A71 RNA level and protein level in Hsp27&#x02013;WT&#x02010;expressing cells (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S8A,C</xref>). However, the WDPF peptide failed to reduce the EV&#x02010;A71 RNA level or protein level in neither Hsp27&#x02013;S78A&#x02010;expressing cells nor Hsp27&#x02013;KO cells (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S8A,B,D</xref>), emphasizing the importance of S78 phosphorylation for the antiviral ability of the WDPF peptide.</p><p>These results confirmed that the WDPF peptide exerts its antiviral effects after viral entry, hindering the Hsp27/hnRNP A1 translocation through blockage of Hsp27 S78 phosphorylation, thereby suppressing EV&#x02010;A71 replication and translation. Targeting WDPF domain shows strong antiviral potent for the development of anti&#x02010;EV&#x02010;A71 drugs.</p></sec><sec id="mco270032-sec-0090"><label>2.7</label><title>Potent antiviral activity of WDPF peptide against both RNA virus HCoV&#x02010;OC43 and DNA virus HSV&#x02010;1 infection</title><p>Considering that Hsp27 is associated with the life cycle of multiple viruses, we investigated whether the WDPF peptide also suppresses infections by other types of viruses. Hsp27 was reported to be upregulated in SARS&#x02010;CoV2&#x02010;infected patients.<xref rid="mco270032-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref> We found that hnRNP A1 knockdown dramatically reduced the RNA level of an enveloped RNA virus, human coronavirus HCoV&#x02010;OC43 (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S9A</xref>). Then, we further tested the effect of the WDPF peptide on the infection of HCoV&#x02010;OC43. Using a CPE assay in RD cells at the MOI of 1 for 48&#x000a0;h, we found that the WDPF peptide successfully protected CPE from HCoV&#x02010;OC43 infection, while peptide &#x00394;WDPF had only mild protection (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5A</xref>). The WDPF peptide decreased the HCoV&#x02010;OC43 RNA level by near 70%, while peptide &#x00394;WDPF only mildly reduced the RNA level by about 10% at the concentration of 25&#x000a0;&#x000b5;M (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S10D,E</xref>). The nucleocapsid (N) protein level of HCoV&#x02010;OC43 was effectively reduced by the WDPF peptide, while peptide &#x00394;WDPF had no detectable effect on the viral protein level (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5E</xref>). In terms of viral propagation, the WDPF peptide decreased the viral titer by 65%, while peptide &#x00394;WDPF showed no effect on virus yield (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5G</xref>).</p><fig position="float" fig-type="FIGURE" id="mco270032-fig-0005"><label>FIGURE 5</label><caption><p>Inhibition of HCoV&#x02010;OC43 and HSV&#x02010;1 replication and propagation by WDPF. (A and B) RD cells were treated with peptides and then infected with HCoV&#x02010;OC43 at the MOI of 1 for 48&#x000a0;h or with HSV&#x02010;1 at the MOI of 0.5 for 24&#x000a0;h. The virus&#x02010;induced CPE was captured. (C and D) Intracellular viral DNA was extracted and quantified by qPCR. The EC<sub>50</sub> of the WDPF peptide is 15.52&#x000a0;&#x000b5;M. (E and F) HCoV&#x02010;OC43 N protein or HSV&#x02010;1 gD protein were detected. (G and H) Viral titration was calculated by TCID<sub>50</sub>. (I) RD cells were pretreated with peptides at the concentration of 25&#x000a0;&#x000b5;M. For the combined peptide treatment, the concentration of each peptide is 25&#x000a0;&#x000b5;M. Then, the cells were infected with virus. HSV&#x02010;1 gD protein were detected. (J) Intracellular viral RNA was extracted and quantified by qPCR. (K) Intracellular viral DNA was collected and quantified by qPCR. Statistical analyses were carried out using Student's <italic toggle="yes">t</italic>&#x02010;test. Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD.</p></caption><graphic xlink:href="MCO2-6-e70032-g001" position="anchor" id="jats-graphic-11"/></fig><p>The depletion of Hsp27 has been verified to reduce the herpes simplex virus 1 (HSV&#x02010;1) replication.<xref rid="mco270032-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref> We also found that hnRNP A1 knockdown markedly decreased the DNA level of HSV&#x02010;1 (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S9B</xref>). HSV&#x02010;1, an enveloped double&#x02010;strained DNA virus, infects humans and causes painful blisters or ulcers and is associated with an increased risk of Alzheimer's disease, amyotrophic lateral sclerosis, and other central nervous system disorder.<xref rid="mco270032-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>, <xref rid="mco270032-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref> We further examined the antiviral effects of the WDPF peptide on HSV&#x02010;1 infection. The WDPF peptide markedly inhibited HSV&#x02010;1&#x02010;induced CPE, while &#x00394;WDPF had no inhibitory effect (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5B</xref>). The WDPF peptide effectively reduced the intracellular HSV&#x02010;1 DNA level in a dose&#x02010;dependent manner, with a 90% reduction at 25&#x000a0;&#x000b5;M (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5C</xref>), while &#x00394;WDPF failed to decrease the viral DNA level (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5D</xref>). The WDPF peptide, but not peptide &#x00394;WDPF, largely decreased HSV&#x02010;1 glycoprotein D (gD) protein level in a dose&#x02010;dependent manner (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5F</xref>) and reduced the viral titer by more than 20 folds (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5H</xref>).</p><p>Hepatitis type B virus (HBV) is a DNA virus undergoing reverse&#x02010;transcription in the life cycle and a main cause of viral hepatitis, liver cirrhosis and hepatocellular carcinoma.<xref rid="mco270032-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref>, <xref rid="mco270032-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref>, <xref rid="mco270032-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> It was reported that high expression of Hsp27 correlates with the prognosis of the patients with HBV&#x02010;associated hepatocellular carcinoma.<xref rid="mco270032-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref> It is a great interest for us to know if the WDPF peptide inhibits HBV replication. We showed that the peptide WDPF decreased the core promoter activity by over 35% shown by a luciferase reporter assay, while peptide &#x00394;WDPF has little effects on the luciferase reporter activity (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S11A</xref>). These results indicate that the WDPF peptide inhibits the transcription of HBV pregenomic RNA and corresponding viral protein expression. The WDPF peptide dramatically decreased the HBV DNA level by 82%, however peptide &#x00394;WDPF had no effect on the DNA level (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S11B</xref>). Thus, the WDPF peptide suppresses the replication and transcription of HBV.</p><p>Given that the WDPF peptide can inhibit S78 phosphorylation of Hsp27 in a dose&#x02010;dependent manner, it could function through the same mechanism as the peptide S78.<xref rid="mco270032-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> We also assessed the effects of S78 and the control peptide S78A on HCoV&#x02010;OC43 and HSV&#x02010;1 infection. At 25 &#x000b5;M, S78 and S78A decreased the HCoV&#x02010;OC43 RNA level by 55% and 46%, respectively (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S10F,G</xref>). For HCoV&#x02010;OC43 reproduction, S78 effectively reduced the viral titer by 65%, while S78A mildly decreased the viral titer by 35% (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5G</xref>). For HSV&#x02010;1, the gD protein and DNA levels were reduced by S78 and S78A in a dose&#x02010;dependent manner (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S10A&#x02013;C</xref>). S78 and S78A decreased the HSV&#x02010;1 titer by 68% and 44%, respectively (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5H</xref>). However, the inhibitory effect of S78 was milder than that of the WDPF peptide. For HBV, S78 and S78A have no dramatic effect on both the core promoter activity and DNA level (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S11</xref>), indicating that the WDPF peptide may not inhibit HBV infection through the suppression of S78 phosphorylation of Hsp27.</p><p>To investigate the combined effect of the peptides, RD cells were treated with 25&#x000a0;&#x000b5;M of peptides WDPF and S78 before virus infection. As shown in Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5A,B</xref>, the WDPF and S78 combination effectively protected CPE from HCoV&#x02010;OC43 and HSV&#x02010;1 infection, while the &#x00394;WDPF and S78A combination did not show dramatic inhibition on the virus&#x02010;induced CPE. The WDPF and S78 combination also further suppressed HSV&#x02010;1 protein (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5I</xref>). For the HCoV&#x02010;OC43 RNA level and viral titer, the WDPF and S78 combination had a similar effect to the WDPF or S78 treatment alone (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5G,J</xref>), indicating that these two peptides suppress the HCoV&#x02010;OC43 infection through the same mechanism. However, in the cases of HSV&#x02010;1 and HBV infections, the antiviral activity of WDPF and S78 combination was similar to that of the WDPF peptide (Figures&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5H,K</xref> and <xref rid="mco270032-supinfo-0001" ref-type="">S11</xref>), no synergistic effect was observed.</p><p>Additionally, we investigated the effect of the peptides on the interferon&#x02010;sensitive response element (ISRE) activity. HEK293T cells were transfected with Hsp27, pISRE (Fluc&#x02010;expressing), and pRF (Rluc&#x02010;expressing) luciferase reporter plasmids and treated with peptides. The normalized ratio of Fluc to Rluc, which represented the relative ISRE activity, was not affected by the peptide treatments after recombinant IFN&#x003b1; stimulation (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S12</xref>). Therefore, the inhibitory effect of the peptides on virus infection is not through the induction of the interferon response.</p></sec><sec id="mco270032-sec-0100"><label>2.8</label><title>Additional antiviral activity of WDPF peptide and Sorafenib combination</title><p>Sorafenib, an inhibitor of multiple kinases including serine, threonine, and tyrosine kinases, is an FDA&#x02010;approved drug for treating primary kidney cancer and liver cancer.<xref rid="mco270032-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref>, <xref rid="mco270032-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref> It was reported that Sorafenib inhibits EV&#x02010;A71 replication through the regulation of viral IRES&#x02010;dependent protein translation.<xref rid="mco270032-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> We investigated whether the peptide could achieve additional antiviral effects when combined with Sorafenib treatment.</p><p>The CPE assay demonstrated that Sorafenib treatment largely protected the cells from HCoV&#x02010;OC43 infection at 8&#x000a0;&#x000b5;M, but only mildly inhibited HSV&#x02010;1&#x02010;induced CPE (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6A</xref>). Sorafenib decreased the HCoV&#x02010;OC43 RNA level in a dose&#x02010;dependent manner, with a 98% reduction at a concentration of 8&#x000a0;&#x000b5;M. The results showed that the WDPF peptide enhanced Sorafenib's antiviral effects, as the same level of RNA reduction was achieved at only 4&#x000a0;&#x000b5;M of Sorafenib, indicating additional antiviral effect (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6B</xref>). Consistent with the viral RNA reduction, the N protein level of HCoV&#x02010;OC43 decreased to an undetectable level by western blot assay when Sorafenib was used in combination with 25&#x000a0;&#x000b5;M of the WDPF peptide (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6C</xref>). The WDPF and Sorafenib individually reduced the HCoV&#x02010;OC43 titer by 1.4 and 2.7 logs, respectively, while the combined treatment of WDPF and Sorafenib decreased the titer by 4.8 logs (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6F</xref>). Furthermore, the WDPF combined with Sorafenib completely blocked S78 phosphorylation of Hsp27, further demonstrating its importance in virus propagation (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6C</xref>).</p><fig position="float" fig-type="FIGURE" id="mco270032-fig-0006"><label>FIGURE 6</label><caption><p>Inhibition of HCoV&#x02010;OC43 and HSV&#x02010;1 replication and propagation by combined treatment of Sorafenib and WDPF. (A) RD cells were treated with Sorafenib and WDPF at indicated concentration and then infected with HCoV&#x02010;OC43 (MOI&#x000a0;=&#x000a0;1, 48&#x000a0;h) or HSV&#x02010;1 (MOI&#x000a0;=&#x000a0;0.5, 24&#x000a0;h). The virus&#x02010;induced CPE was captured. (B) Intracellular viral RNA was extracted and quantified by qPCR. (C) The protein levels of HCoV&#x02010;OC43 N protein, pHsp27&#x02013;S78, and Hsp27 were detected. (D) Intracellular viral DNA was extracted and quantified by qPCR. (E) The protein levels of HSV&#x02010;1 gD protein, pHsp27&#x02013;Ser78, and Hsp27 were detected. (F and G) Viral titration was calculated by TCID<sub>50</sub>. Statistical analyses were carried out using Student's <italic toggle="yes">t</italic>&#x02010;test. Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD.</p></caption><graphic xlink:href="MCO2-6-e70032-g003" position="anchor" id="jats-graphic-13"/></fig><p>In the case of the DNA virus HSV&#x02010;1, Sorafenib failed to suppress viral DNA replication and protein synthesis, although it potently inhibited the phosphorylation at S78 of Hsp27 (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6D,E</xref>). Notably, the WDPF alone potently reduced the DNA level by 98%. Combined with 8&#x000a0;&#x000b5;M of Sorafenib treatment, the DNA level of HSV&#x02010;1 was further decreased by 70% (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6D</xref>); and interestingly, the viral gD protein level significantly decreased in a Sorafenib dose&#x02010;dependent manner (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6E</xref>). The combined treatment decreased the titer by 85%, while the WDPF peptide and Sorafenib reduced it by 68 and 62%, respectively (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6G</xref>). In summary, the combined treatment of the WDPF and Sorafenib achieves additional inhibitory effects on both HCoV&#x02010;OC43 and HSV&#x02010;1 infection.</p></sec></sec><sec id="mco270032-sec-0110"><label>3</label><title>DISCUSSION</title><p>Hsp27 functions through its dynamic structure regulated by oligomerization and oligomer dissociation.<xref rid="mco270032-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref> Hsp27 consists of a less conserved N&#x02010;terminal region (NTR) containing a WDPF domain, a highly conserved ACD domain, and a flexible C&#x02010;terminal domain. The ACD domain forms two &#x003b2;&#x02010;sheets with six &#x003b2;&#x02010;strands, providing a &#x003b2;4/&#x003b2;8 groove and a dimer interface groove for oligomerization and protein interaction.<xref rid="mco270032-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref>, <xref rid="mco270032-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref> The flexible C&#x02010;terminal domain is responsible for Hsp27 oligomers formation and solubility.<xref rid="mco270032-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> The IXI motif near the C&#x02010;terminus interacts with the &#x003b2;4/&#x003b2;8 groove of the ACD domain.<xref rid="mco270032-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref>, <xref rid="mco270032-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> The N&#x02010;terminal WDPF domain is involved both in the oligomer formation and the chaperone activity.<xref rid="mco270032-bib-0059" ref-type="bibr">
<sup>59</sup>
</xref> Clouser et&#x000a0;al.<xref rid="mco270032-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> have reported that four distinct regions of NTR interact with the ACD domain, including the distal region (1&#x02010;13) with the &#x003b2;4/&#x003b2;8 groove, the aromatic region (12&#x02013;27) with loops L3/4 and L5/6, the conserved region (25&#x02013;37), and the boundary region (74&#x02013;91) with the dimer interfaced groove. The complicated composition contributes to the dynamic Hsp27 oligomer size and its diverse functions. Furthermore, the aromatic region (12&#x02013;27), including WDPF motif and serine 15, is in close spatial proximity to S78 and S82. Thus, all the three phosphorylation sites are located near the negatively charged ACD region, making them susceptible to phosphorylation&#x02010;induced changes.<xref rid="mco270032-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> Interestingly, Hsp27 phosphorylation in response to various stresses is responsible for the tunability of Hsp27 oligomers.<xref rid="mco270032-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> Previously, we reported that Hsp27 is hijacked by EV&#x02010;A71 to facilitate Hsp27/hnRNP A1 translocation and EV&#x02010;A71 replication through phosphorylation of S78 of Hsp27.<xref rid="mco270032-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="mco270032-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> Thus, we hypothesized that Hsp27 domains may play critical roles in promoting EV&#x02010;A71 infection, in conjunction with Hsp27 phosphorylation.</p><p>In this study, the deletion of ACD domain led to low expression level of Hsp27&#x00394;ACD, Hsp27&#x00394;ACD/WDPF, and Hsp27&#x00394;ACD/Flex, indicating the essential role of ACD domain for Hsp27 expression as a highly conserved core domain. The low expression of these mutants could result in the disturbance of Hsp27 function and probably the absence of Hsp27&#x02010;mediated mechanisms. Under this intricated condition, little expression of the Hsp27 mutants has the similar effect with knockout of Hsp27. Thus, the effect of the ACD domain remain complicated. The flexible C&#x02010;terminal domain deletion did not significantly affect the hnRNP A1&#x02010;mediated EV&#x02010;A71 translation. Importantly, the deletion of WDPF domain induced Hsp27 to localize in both cytoplasm and nucleus. However, upon EV&#x02010;A71 infection, the nuclear translocation of Hsp27&#x02013;&#x00394;WDPF failed to promote cytosolic relocalization of hnRNP A1 (Figures&#x000a0;<xref rid="mco270032-fig-0001" ref-type="fig">1</xref> and&#x000a0;<xref rid="mco270032-fig-0002" ref-type="fig">2</xref>).</p><p>The WDPF peptide, developed to competitively inhibit the endogenous Hsp27 WDPF function, did not affect the subcellular localization of endogenous Hsp27 (Figure&#x000a0;<xref rid="mco270032-fig-0003" ref-type="fig">3</xref>), suggesting that the deletion of the WDPF domain may generate an unknown NLS or alter the Hsp27 conformation to facilitate Hsp27 nuclear import. However, the WDPF peptide dramatically suppressed Hsp27 phosphorylation at S78, accompanied by the blockage of hnRNP A1 relocalization and reduction of viral IRES activity. The WDPF peptide also strongly protected RD cells from the EV&#x02010;A71&#x02010;induced CPE, and dramatically decreased viral replication and translation. The viral titer was decreased by over 450 folds in cells treated with the WDPF peptide (Figure&#x000a0;<xref rid="mco270032-fig-0004" ref-type="fig">4</xref>). In contrast, peptide &#x00394;WDPF, with a shorter region of domain WDPF, failed to suppress Hsp27 phosphorylation at any serine site, hamper hnRNP A1 translocation, or inhibit viral IRES&#x02010;dependent translation and viral reproduction.</p><p>HSV&#x02010;1 is a double&#x02010;stranded DNA virus. It was reported that HSV&#x02010;1 induces Hsp27 phosphorylation and translocation into nucleus.<xref rid="mco270032-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref> Interestingly, knockdown of hnRNP A1 reduced the DNA level of HSV&#x02010;1. Then, we investigated the effect of WDPF peptide on HSV&#x02010;1 infection. The WDPF peptide was also able to largely suppress the replication and reproduction of HSV&#x02010;1 (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5</xref>). Furthermore, the kinase inhibitor Sorafenib treatment was demonstrated to enhance the inhibition of HSV&#x02010;1 replication and propagation by the WDPF treatment (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6</xref>). Although Sorafenib can also inhibit the S78 phosphorylation of Hsp27 (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6E</xref>), Sorafenib alone failed to decrease the viral replication and translation of HSV&#x02010;1. These results suggest that the reduced S78 phosphorylation may be a partial reason for the inhibitory effect of WDPF on HSV&#x02010;1 infection. The WDPF peptide may disrupt additional Hsp27&#x02010;dependent processes, such as its chaperone function, viral entry and trafficking, host stress response, and impact on apoptosis and cell survival pathways, all of which could impair viral replication and spread.<xref rid="mco270032-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="mco270032-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref>, <xref rid="mco270032-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref>
</p><p>It is also amusing that the peptide WPDF also potently inhibits HBV replication, as HBV infection largely contributes to liver disease related death in Asia and Africa. The WDPF peptide significantly decreased both HBV replication and transcription, while the &#x00394;WDPF peptide had no effect (Figure <xref rid="mco270032-supinfo-0001" ref-type="">S11</xref>). To our surprise, the S78 peptide failed to reduce the HBV replication, indicating that S78 phosphorylation of Hsp27 is not associated with HBV infection. Similar to HSV&#x02010;1, the WDPF peptide suppresses HBV replication through other mechanisms.</p><p>Additionally, knockdown of hnRNP A1 also reduced the RNA level of HCoV&#x02010;OC43. WDPF peptide significantly decreased the viral propagation of HCoV&#x02010;OC43 (Figure&#x000a0;<xref rid="mco270032-fig-0005" ref-type="fig">5</xref>). The combined treatment with the WDPF peptide and Sorafenib had an additional antiviral effect on HCoV&#x02010;OC43 infection (Figure&#x000a0;<xref rid="mco270032-fig-0006" ref-type="fig">6</xref>). These results demonstrate an effective broad&#x02010;spectrum antiviral peptide. The combination of new peptide and approved drug further leads to the increased potency and therapeutic impact.</p><p>Although the crucial domain and phosphorylation site of Hsp27 involved in the induction of hnRNP A1 redistribution have been identified in this study, the detailed mechanisms underlying this process remain elusive. Previous studies have reported that the poliovirus and rhinovirus 2A<sup>pro</sup> can cleave the nuclear pore glycoproteins such as NUP62, NUP98, and NUP153, thereby disrupting the nucleocytoplasmic dynamic.<xref rid="mco270032-bib-0062" ref-type="bibr">
<sup>62</sup>
</xref>, <xref rid="mco270032-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref>, <xref rid="mco270032-bib-0064" ref-type="bibr">
<sup>64</sup>
</xref>, <xref rid="mco270032-bib-0065" ref-type="bibr">
<sup>65</sup>
</xref> This cleavage can lead to significant alterations in the transport of proteins and RNA between the nucleus and cytoplasm. The rhinovirus 3C protease was shown to cleave Nup153 and induce the redistribution of the essential splicing factors SC35 and nucleolin.<xref rid="mco270032-bib-0066" ref-type="bibr">
<sup>66</sup>
</xref> Interestingly, HIV&#x02010;1 was reported to alter the abundance and localization of NUP62, thereby blocking the nuclear import pathway that leads to the exported hnRNP A1 accumulates in the cytoplasm.<xref rid="mco270032-bib-0067" ref-type="bibr">
<sup>67</sup>
</xref> These studies highlighted that viruses regulate the nuclear transport pathway to benefit their life cycle in the host cells. As an enterovirus, it is plausible that EV&#x02010;A71 2A<sup>pro</sup> could cleave the nuclear pore glycoproteins, resulting in the cytoplasmic accumulation of hnRNP A1. Alternatively, 2A<sup>pro</sup> may trigger posttranslational modification of hnRNP A1 with the help of Hsp27 to promote hnRNP A1 nuclear export. By dissecting these detailed pathways, we may uncover multiple innovative strategies for developing effective antiviral therapies to mitigate the impact of EV&#x02010;A71 and related viral infections.</p><p>In summary, Hsp27&#x00394;WDPF lost the normal Hsp27&#x02013;WT pattern and localized in the nucleus without any stimuli. At the same time, Hsp27&#x00394;WDPF failed to induce hnRNP A1 nuclear translocation upon EV&#x02010;A71 infection, leading to further reduction in IRES activity and viral replication. The WDPF peptide was developed to inhibit EV&#x02010;A71&#x02010;induced hnRNP A1 translocation and viral IRES activity, while peptide &#x00394;WDPF failed to do so. Importantly, the WDPF peptide dramatically suppressed S78 phosphorylation of Hsp27 upon EV&#x02010;A71 infection, strongly inhibiting viral replication and propagation. Furthermore, when combined with the approved anticancer drug Sorafenib, the WDPF peptide had additional inhibitory effect on HCoV&#x02010;OC43 and HSV&#x02010;1 infection, offering a new avenue for the development of broad&#x02010;spectrum antiviral therapies.</p></sec><sec id="mco270032-sec-0120"><label>4</label><title>MATERIALS AND METHODS</title><sec id="mco270032-sec-0130"><label>4.1</label><title>Cells and virus</title><p>Human embryonic kidney 293T (HEK293T) cells and rhabdomyosarcoma (RD) cells (ATCC <sup>#</sup>CCL&#x02010;136) were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum, 100&#x000a0;U/mL of penicillin, and 100&#x000a0;&#x000b5;g/mL of streptomycin. Hsp27 knockout RD cells (Hsp27&#x02013;KO RD cells) were previously generated using the CRISPR/Cas 9 system and maintained in the lab.<xref rid="mco270032-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> The targeting single&#x02010;guide RNA sequence was 5&#x02032;&#x02010;GCAUAGCCGCCUCUUCGACC&#x02010;3&#x02032;. All the cells used in this study have undergone the authentication by STR analysis and mycoplasma test. EV&#x02010;A71 was obtained from the Shenzhen Center for Disease Control and Prevention (SHZH98 strain, GenBank accession number AF302996). HSV&#x02010;1 (HSV&#x02010;1, VR&#x02010;1493&#x02122;) and human coronavirus OC43 (HCoV&#x02010;OC43, VR&#x02010;1558&#x02122;) were purchased from ATCC. All viruses were propagated, aliquoted, and stored at &#x02212;80&#x000b0;C until further use, as described previously.<xref rid="mco270032-bib-0068" ref-type="bibr">
<sup>68</sup>
</xref>
</p></sec><sec id="mco270032-sec-0140"><label>4.2</label><title>Plasmids</title><p>The EV&#x02010;A71 IRES reporter plasmid, pcDNA4/HisMax B&#x02010;2A<sup>pro</sup>, and pcDNA4/HisMax B&#x02010;2A<sup>C110A</sup> were generated as previously described.<xref rid="mco270032-bib-0069" ref-type="bibr">
<sup>69</sup>
</xref>, <xref rid="mco270032-bib-0070" ref-type="bibr">
<sup>70</sup>
</xref> The protease&#x02010;inactive mutation of 2A<sup>pro</sup> (Cys<sup>110</sup> to Ala<sup>110</sup>, 2A<sup>C110A</sup>) was generated by site&#x02010;directed mutagenesis with a one&#x02010;step mutagenesis kit (Invitrogen). To construct EV&#x02010;A71 IRES reporter plasmid, the Rluc gene was inserted into pcDNA4/HisMax B between <italic toggle="yes">Bam</italic>H I and <italic toggle="yes">Eco</italic>R V sites first, then the amplified IRES&#x02010;Fluc encoding sequence was inserted downstream of the Rluc using <italic toggle="yes">Eco</italic>R V and <italic toggle="yes">Xba</italic>r I. The primers used in amplification are available upon request. The pcDNA4/HisMax B&#x02013;Hsp27 and pcDNA4/HisMax B&#x02013;Hsp27&#x02013;S78A were described previously.<xref rid="mco270032-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> The HBV (subtype adr) genomic clone pHBV&#x02010;adr was a gift from Professor Yuan Wang, Shanghai Institute of Biochemistry, Academia Sinica.<xref rid="mco270032-bib-0071" ref-type="bibr">
<sup>71</sup>
</xref> The 1.3xHBV&#x02010;Luciferase plasmid to monitor HBV transcription was purchased from Addgene (#61549; Addgene, USA). Luciferase was inserted within Core ORF and regulated by EnhII&#x02013;Core promoter.</p></sec><sec id="mco270032-sec-0150"><label>4.3</label><title>Lentivirus package</title><p>Lentiviral vectors were prepared as described previously.<xref rid="mco270032-bib-0072" ref-type="bibr">
<sup>72</sup>
</xref> Briefly, the plasmids (pLV&#x02013;Hsp27&#x02013;EGFP&#x02013;Flag, pLV&#x02013;Hsp27&#x02013;&#x00394;ACD&#x02013;EGFP&#x02013;Flag, pLV&#x02013;Hsp27&#x02013;&#x00394;WDPF&#x02013;EGFP&#x02013;Flag, pLV&#x02013;Hsp27&#x02013;&#x00394;FLEX&#x02013;EGFP&#x02013;Flag, pLV&#x02013;Hsp27&#x02013;&#x00394;ACD/WDPF&#x02013;EGFP&#x02013;Flag, pLV&#x02013;Hsp27&#x02013;&#x00394;ACD/FLEX&#x02013;EGFP&#x02013;Flag, pLV&#x02013;Hsp27&#x02013;&#x00394;WDPF/FLEX&#x02013;EGFP&#x02013;Flag, and pLV&#x02013;hnRNPA1&#x02013;mcherry&#x02013;Flag) were constructed by Inovogen Tech. Co. Then, these plasmids were cotransfected with the psPAX2 (packaging) and pMD2.G (envelope) plasmids into HEK293T cells using polyethylenimine as the transfection reagent. The ratio of the plasmids used was psPAX2:pMD2.G:lentiviral transfer plasmid&#x000a0;=&#x000a0;6:3:9&#x000a0;&#x000b5;g. The culture medium was replaced 2&#x02013;4&#x000a0;h after transfection. After 96&#x000a0;h, the supernatant containing the lentiviral particles was collected, aliquoted, and stored at &#x02212;80&#x000b0;C.</p></sec><sec id="mco270032-sec-0160"><label>4.4</label><title>Immunofluorescence assay</title><p>We followed a previously reported protocol to study the distribution of hnRNP A1.<xref rid="mco270032-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> In brief, cells cultured on coverslips were infected with EV&#x02010;A71 at an MOI of 40 for 6&#x000a0;h to ensure a high efficiency of viral infection. After infection, the cells were fixed with 4% paraformaldehyde for 20 min and permeabilized with 0.5% Triton X&#x02010;100 for 15 min. The cells were then blocked with 5% bovine serum albumin (BSA) for 2&#x000a0;h. The cells with stable expression of Hsp27&#x02013;eGFP and hnRNP A1&#x02013;mCherry were directly stained with Hoechst. The RD cells treated with peptides were incubated with primary antibodies against Hsp27 (GTX101145) and hnRNP A1 (sc&#x02010;32301), followed by incubation with Alexa Fluor 488&#x02010;conjugated anti&#x02010;rabbit and Alexa Fluor 594&#x02010;conjugated anti&#x02010;mouse secondary antibodies, respectively. After four washes with 0.2% Triton X&#x02010;100, the cell nuclei were stained with Hoechst for 5 min. The stained cells were imaged using a Nikon A1HD25 high&#x02010;speed and large field&#x02010;of&#x02010;view confocal microscope. Colocalization analysis was conducted using the JACoP&#x02010;plugin in the Fiji (ImageJ) software. The Mander's M1 colocalization coefficient was computed to quantify the colocalization levels of Hsp27 or hnRNP A1 overlapped with Hoechst.</p></sec><sec id="mco270032-sec-0170"><label>4.5</label><title>Luciferase assay</title><p>The reporter plasmids used in this study were described previously.<xref rid="mco270032-bib-0069" ref-type="bibr">
<sup>69</sup>
</xref> HEK 293T cells were seeded in 24&#x02010;wells, and then cotransfected with the following plasmids: 2A<sup>pro</sup> expression plasmid (200&#x000a0;ng), pIRES reporter plasmid (200&#x000a0;ng), and the plasmid expressing wild&#x02010;type Hsp27 or its mutants (800&#x000a0;ng). After culturing for 24&#x000a0;h, the transfected cells were lysed using a passive lysis buffer (Promega, USA). The Rluc and Fluc activities in the cell lysates were measured using the dual&#x02010;luciferase reporter assay system (Promega) according to the manufacturer's instructions. The luminescence was detected using a Lumat LB9507 bioluminometer.</p></sec><sec id="mco270032-sec-0180"><label>4.6</label><title>RNA isolation</title><p>Total cellular RNA was isolated using the established protocol described previously.<xref rid="mco270032-bib-0073" ref-type="bibr">
<sup>73</sup>
</xref> Briefly, the cells were lysed with TRIzol reagent (Ambion, Life Technologies), and the intracellular RNA was extracted according to the manufacturer's instructions. Alternatively, TRIzol reagent was added into the supernatant solution of the cells (TRIzol:solution&#x000a0;=&#x000a0;1:1), and the extracellular RNA was extracted according to the manufacturer's instructions. For cDNA synthesis, 1&#x000a0;&#x000b5;g of the isolated total RNA was used as the input for reverse transcription. The cDNA was synthesized using the PrimeScript&#x02122; RT Master Mix (Takara) following the manufacturer's protocol. For DNA virus, total cellular DNA was isolated using the QIAamp DNA&#x000a0;Mini and Blood Mini Extraction Kit.</p></sec><sec id="mco270032-sec-0190"><label>4.7</label><title>Quantitative RT&#x02010;PCR</title><p>Quantitative real&#x02010;time PCR (RT&#x02010;qPCR) was performed using TB Green&#x000ae; Premix Ex Taq&#x02122; (Takara) on the Applied Biosystems QuantStudio&#x02122; 3 Real&#x02010;Time PCR Systems. The thermal cycling conditions for the RT&#x02010;qPCR were as follows: initial activation at 95&#x000b0;C for 30&#x000a0;s, followed by 45 cycles of amplification, with each cycle consisting of 95&#x000b0;C for 5&#x000a0;s and 60&#x000b0;C for 30&#x000a0;s. After the amplification cycles, a melting temperature analysis was carried out by slowly increasing the temperature from 60 to 95&#x000b0;C at a rate of 0.1&#x000b0;C/s to verify the specificity of the amplified products. The primer sequences used for the target gene amplification were:</p><p>EV&#x02010;A71 VP1, F 5&#x02032;&#x02010;CGGACTGTAGGCACCTCGAA&#x02010;3&#x02032;, R 5&#x02032;&#x02010;CGCATTGGGCGAGGTATC&#x02010;3&#x02032;;</p><p>GAPDH, F 5&#x02032;&#x02010;GTCTCCTCTGACTTCAACAGCG&#x02010;3&#x02032;, R 5&#x02032;&#x02010;ACCACCCTGTTGCTGTAGCCAA&#x02010;3&#x02032;;</p><p>HSV&#x02010;1 UL1, F 5&#x02032;&#x02010;GCCAGCGAGACGCTGAT&#x02010;3&#x02032;, R 5&#x02032;&#x02010;ACGCAGGTACTCGTGGTGA&#x02010;3&#x02032;;</p><p>HCoV&#x02010;OC43 NSP1, F 5&#x02032;&#x02010;TTGTGAGCGATTTGCGTGCG&#x02010;3&#x02032;, R 5&#x02032;&#x02010;ACACGTCCCTGGCTGAAAGC&#x02010;3&#x02032;;</p><p>HBV core, F 5&#x02032;&#x02010;AGTGTGGATTCGCACTCCT&#x02010;3&#x02032;, R 5&#x02032;&#x02010;GAGTTCTTCTTCTAGGGGACCTG&#x02010;3&#x02032;.</p><p>The messenger RNA (mRNA) expression levels of each target gene were normalized to the mRNA copies of GAPDH in the same samples, as previously described.<xref rid="mco270032-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>
</p></sec><sec id="mco270032-sec-0200"><label>4.8</label><title>Peptide treatment</title><p>The peptides used in this study were constructed and purchased from GL Biochem (Shanghai) Ltd. RD cells were seeded into 24&#x02010;well plates and cultured for 24&#x000a0;h. The cells were then pretreated with the peptides at the indicated concentrations for 2&#x000a0;h and were either infected with EV&#x02010;A71 or transfected with plasmids for further experiments. The amino acids sequences of the peptides were RKKRRQRRR&#x02010;AYSRALSRQLSS (TAT&#x02010;S78, S78), RKKRRQRRR&#x02010;AYSRALARQLSS (TAT&#x02010;S78A, S78A), RKKRRQRRR&#x02010;WDPFRDWYPHSR (TAT&#x02010;WDPF, WDPF), RKKRRQRRR&#x02010;DWYPHSR (TAT&#x02010;&#x00394;WDPF, &#x00394;WDPF), and WDPFRDWYPHSR (NoTAT&#x02010;WDPF, NT&#x02010;WDPF).</p></sec><sec id="mco270032-sec-0210"><label>4.9</label><title>Western blot assay</title><p>The Western blot protocol used in this study has been described previously.<xref rid="mco270032-bib-0074" ref-type="bibr">
<sup>74</sup>
</xref> Briefly, the cells were lysed in Nonidet&#x02010;P40 (NP&#x02010;40) buffer, and the cell lysates were centrifuged. The protein concentration in the cell lysates was determined using the Bradford assay (Bio&#x02010;Rad). A total of 20&#x000a0;&#x000b5;g of protein from each sample was resolved on a 12% SDS&#x02010;PAGE gel and then transferred onto a polyvinylidene fluoride membrane (GE, MA, USA). After blocking the membrane with 5% BSA for 1&#x000a0;h, the membrane was incubated with primary antibodies (diluted 1:1000) against the following proteins overnight at 4&#x000b0;C: Hsp27 (sc&#x02010;13132; Santa Cruz), pHsp27&#x02013;Ser15 (ab76313; abCam), pHsp27&#x02013;Ser78 (ADI&#x02010;SPA&#x02010;523; Enzo), pHsp27&#x02013;Ser82 (ab155987; abCam), VP1 (GTX132339; GeneTex), Actin (sc&#x02010;47778; Santa Cruz)), hnRNP A1 (sc&#x02010;32301; Santa Cruz)), OctA&#x02013;Probe (Flag, sc&#x02010;166355; Santa Cruz)), HSV&#x02010;1 gD (sc&#x02010;21719; Santa Cruz), HCoV&#x02010;OC43 N (40643&#x02010;T62; Sino), or GAPDH (sc&#x02010;32233; Santa Cruz)) overnight in 4&#x000b0;C. After secondary antibodies (HRP&#x02010;conjugated Affinipure Goat Anti&#x02010;Mouse IgG(H+L), SA00001&#x02010;1, and HRP&#x02010;conjugated Affinipure Goat Anti&#x02010;Rabbit IgG(H+L), SA00001&#x02010;2; ProteinTech) incubation for 2&#x000a0;h, the protein band was visualized using a chemiluminescence reagent (PerkinElmer, MA, USA) and imaged using the Bio&#x02010;Rad Chemidoc Imaging System. If necessary, the protein bands were quantified by densitometry analysis using ImageJ software.</p></sec><sec id="mco270032-sec-0220"><label>4.10</label><title>Virus titration</title><p>RD cells were seeded into 96&#x02010;well plates and incubated for 24&#x000a0;h. The cells were then infected with 100&#x000a0;&#x000b5;L per well of serially diluted virus supernatant, with each dilution tested in quintuplicate. The serial dilutions of the virus supernatant were prepared as 10&#x02010;fold dilutions in the appropriate cell culture medium. After 120&#x000a0;h of incubation postinfection, the 50% tissue culture infectious dose (TCID<sub>50</sub>) was calculated using the K&#x000e4;rber method, as described previously.<xref rid="mco270032-bib-0069" ref-type="bibr">
<sup>69</sup>
</xref>, <xref rid="mco270032-bib-0070" ref-type="bibr">
<sup>70</sup>
</xref>
</p></sec><sec id="mco270032-sec-0230"><label>4.11</label><title>RNA interference</title><p>A small interfering RNA (siRNA) targeting human hnRNP A1 mRNA (si hnRNP A1) was designed (sense primer 5&#x02032;&#x02010;GCUCUUCAUUGGAGGGUUG&#x02010;3&#x02032;) and synthesized by GenePharma (Shanghai, China). Western blot assays were applied to measure the knockdown efficiency of the siRNA. A nonspecific siRNA with no homology to the human genome was used as the negative control.</p></sec><sec id="mco270032-sec-0240"><label>4.12</label><title>CCK&#x02010;8 assay</title><p>RD cells were seeded in 96&#x02010;well cell plates at a density of 1&#x000a0;&#x000d7;&#x000a0;104 cells per well. The cells were then placed in a 5% CO<sub>2</sub> incubator for 24&#x000a0;h. Then, the cells were treated with the peptides at the desired concentrations for 2 days. A total of 90&#x000a0;&#x000b5;L of fresh cell culture medium and 10&#x000a0;&#x000b5;L of CCK&#x02010;8 (BS350B; BioSharp) were added to each well of the 96&#x02010;well plate, which were incubated at 37&#x000b0;C for 1&#x000a0;h. The absorbance of each well was measured using a microplate reader (Synergy H1; BioTek). The absorbance was recorded at a wavelength of 450&#x000a0;nm.</p></sec><sec id="mco270032-sec-0250"><label>4.13</label><title>Statistical analysis</title><p>The experimental results were expressed as the mean&#x000a0;&#x000b1;&#x000a0;standard deviation (SD) for each experimental group. All statistical analyses were carried out using the GraphPad Prism 8.0 software (GraphPad Inc.). For comparisons between two experimental groups, a two&#x02010;tailed Student's <italic toggle="yes">t</italic>&#x02010;test was applied. A <italic toggle="yes">p</italic> value less than 0.05 (<italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) was considered statistically significant.</p></sec></sec><sec id="mco270032-sec-0260"><title>AUTHOR CONTRIBUTIONS</title><p>
<italic toggle="yes">Conceptualization</italic>: Ming&#x02010;Liang He <italic toggle="yes">Methodology</italic>: Mandi Wu and Wei Li <italic toggle="yes">Formal analysis</italic>: Mandi Wu, Wei Li, and Houying Leung <italic toggle="yes">Investigation</italic>: Mandi Wu, Wei Li, Houying Leung, Yiran Wang, Qianya Wan, Peiran Chen, Cien Chen, Yichen Li, Xi Yao, and Ming&#x02010;Liang He <italic toggle="yes">Resources</italic>: Mandi Wu, Wei Li, Houying Leung, Yiran Wang, Qianya Wan, Peiran Chen, Cien Chen, Yichen Li, Xi Yao, and Ming&#x02010;Liang He <italic toggle="yes">Original draft preparation</italic>: Mandi Wu <italic toggle="yes">Review and editing</italic>: Ming&#x02010;Liang He, Mandi Wu, Wei Li, and Yiran Wang <italic toggle="yes">Visualization</italic>: Ming&#x02010;Liang He and Mandi Wu <italic toggle="yes">Supervision</italic>: Ming&#x02010;Liang He <italic toggle="yes">Project administration</italic>: Ming&#x02010;Liang He <italic toggle="yes">Funding acquisition</italic>: Ming&#x02010;Liang He. All authors have read and agreed to the published version of the manuscript.</p></sec><sec sec-type="COI-statement" id="mco270032-sec-0280"><title>CONFLICT OF INTEREST STATEMENT</title><p>Author Ming&#x02010;Liang He is an editorial board member of MedComm. Author Ming&#x02010;Liang He was not involved in the journal's review of or decisions related to this manuscript. The other authors declared no conflict of interest.</p></sec><sec id="mco270032-sec-0310"><title>ETHICS STATEMENT</title><p>Not applicable, as there are no animal/clinical experiments in this study.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="mco270032-supinfo-0001" position="float" content-type="local-data"/><supplementary-material id="mco270032-supitem-0001" position="float" content-type="local-data"><caption><p>Supporting Information</p></caption><media xlink:href="MCO2-6-e70032-s001.pdf"/></supplementary-material></sec></body><back><ack id="mco270032-sec-0270"><title>ACKNOWLEDGMENTS</title><p>The work was partially supported by grants from RGC General Research Fund of Hong Kong Special Administrative Region (11104020) and Strategic funds from City University of Hong Kong (#7005874, #7020032 and #9680149) to M. He.</p></ack><sec sec-type="data-availability" id="mco270032-sec-0300"><title>DATA AVAILABILITY STATEMENT</title><p>The raw data generated from this study are available from the corresponding author M. L. H. on request.</p></sec><ref-list id="mco270032-bibl-0001"><title>REFERENCES</title><ref id="mco270032-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="mco270032-cit-0001">
<string-name>
<surname>Zhu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ji</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Current status of hand&#x02010;foot&#x02010;and&#x02010;mouth disease</article-title>. <source>J Biomed Sci</source>. <year>2023</year>;<volume>30</volume>(<issue>1</issue>):<fpage>15</fpage>.<pub-id pub-id-type="pmid">36829162</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="mco270032-cit-0002">
<string-name>
<surname>Wan</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>ML</given-names>
</string-name>. <article-title>Stress proteins: the biological functions in virus infection, present and challenges for target&#x02010;based antiviral drug development</article-title>. <source>Signal Transduct Target Ther</source>. <year>2020</year>;<volume>5</volume>(<issue>1</issue>):<fpage>125</fpage>.<pub-id pub-id-type="pmid">32661235</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="mco270032-cit-0003">
<string-name>
<surname>Chang</surname>
<given-names>LY</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Gau</surname>
<given-names>SS</given-names>
</string-name>, et&#x000a0;al. <article-title>Enterovirus A71 neurologic complications and long&#x02010;term sequelae</article-title>. <source>J Biomed Sci</source>. <year>2019</year>;<volume>26</volume>(<issue>1</issue>):<fpage>57</fpage>.<pub-id pub-id-type="pmid">31395054</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="mco270032-cit-0004">
<string-name>
<surname>Xing</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Recent advances in enterovirus A71 pathogenesis: a focus on fatal human enterovirus A71 infection</article-title>. <source>Arch Virol</source>. <year>2022</year>;<volume>167</volume>(<issue>12</issue>):<fpage>2483</fpage>&#x02010;<lpage>2501</lpage>.<pub-id pub-id-type="pmid">36171507</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="mco270032-cit-0005">
<string-name>
<surname>Akhmadishina</surname>
<given-names>LV</given-names>
</string-name>, <string-name>
<surname>Govorukhina</surname>
<given-names>MV</given-names>
</string-name>, <string-name>
<surname>Kovalev</surname>
<given-names>EV</given-names>
</string-name>, <string-name>
<surname>Nenadskaya</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Ivanova</surname>
<given-names>OE</given-names>
</string-name>, <string-name>
<surname>Lukashev</surname>
<given-names>AN</given-names>
</string-name>. <article-title>Enterovirus A71 meningoencephalitis outbreak, Rostov&#x02010;on&#x02010;Don, Russia, 2013</article-title>. <source>Emerg Infect Dis</source>. <year>2015</year>;<volume>21</volume>(<issue>8</issue>):<fpage>1440</fpage>&#x02010;<lpage>1443</lpage>.<pub-id pub-id-type="pmid">26196217</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="mco270032-cit-0006">
<string-name>
<surname>Donato</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hoi Le</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hoa</surname>
<given-names>NT</given-names>
</string-name>, et&#x000a0;al. <article-title>Genetic characterization of Enterovirus 71 strains circulating in Vietnam in 2012</article-title>. <source>Virology</source>. <year>2016</year>;<volume>495</volume>:<fpage>1</fpage>&#x02010;<lpage>9</lpage>.<pub-id pub-id-type="pmid">27148893</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="mco270032-cit-0007">
<string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6&#x02013;35 months in China: a non&#x02010;inferiority, randomised controlled trial</article-title>. <source>Lancet Reg Health West Pac</source>. <year>2021</year>;<volume>16</volume>:<elocation-id>100284</elocation-id>.<pub-id pub-id-type="pmid">34881371</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="mco270032-cit-0008">
<string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>L</given-names>
</string-name>. <article-title>Hand&#x02010;foot&#x02010;and&#x02010;mouth disease&#x02010;associated enterovirus and the development of multivalent HFMD vaccines</article-title>. <source>Int J Mol Sci</source>. <year>2022</year>;<volume>24</volume>(<issue>1</issue>):<fpage>169</fpage>.<pub-id pub-id-type="pmid">36613612</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="mco270032-cit-0009">
<string-name>
<surname>Nguyen</surname>
<given-names>TT</given-names>
</string-name>, <string-name>
<surname>Chiu</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>CY</given-names>
</string-name>, et&#x000a0;al. <article-title>Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double&#x02010;blind, randomised, placebo&#x02010;controlled, phase 3 trial</article-title>. <source>Lancet</source>. <year>2022</year>;<volume>399</volume>(<issue>10336</issue>):<fpage>1708</fpage>&#x02010;<lpage>1717</lpage>.<pub-id pub-id-type="pmid">35427481</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="mco270032-cit-0010">
<string-name>
<surname>Nguyen&#x02010;Tran</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Messacar</surname>
<given-names>K</given-names>
</string-name>. <article-title>Preventing enterovirus A71 disease: another promising vaccine for children</article-title>. <source>Lancet</source>. <year>2022</year>;<volume>399</volume>(<issue>10336</issue>):<fpage>1671</fpage>&#x02010;<lpage>1673</lpage>.<pub-id pub-id-type="pmid">35427482</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="mco270032-cit-0011">
<string-name>
<surname>Lin</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Kung</surname>
<given-names>YA</given-names>
</string-name>, <string-name>
<surname>Shih</surname>
<given-names>SR</given-names>
</string-name>. <article-title>Antivirals and vaccines for enterovirus A71</article-title>. <source>J Biomed Sci</source>. <year>2019</year>;<volume>26</volume>(<issue>1</issue>):<fpage>65</fpage>.<pub-id pub-id-type="pmid">31481071</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="mco270032-cit-0012">
<string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>M</given-names>
</string-name>. <article-title>Enterovirus A71 antivirals: past, present, and future</article-title>. <source>Acta Pharm Sin B</source>. <year>2022</year>;<volume>12</volume>(<issue>4</issue>):<fpage>1542</fpage>&#x02010;<lpage>1566</lpage>.<pub-id pub-id-type="pmid">35847514</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="mco270032-cit-0013">
<string-name>
<surname>Baggen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Thibaut</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Strating</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>van Kuppeveld</surname>
<given-names>FJM</given-names>
</string-name>. <article-title>The life cycle of non&#x02010;polio enteroviruses and how to target it</article-title>. <source>Nat Rev Microbiol</source>. <year>2018</year>;<volume>16</volume>(<issue>6</issue>):<fpage>368</fpage>&#x02010;<lpage>381</lpage>.<pub-id pub-id-type="pmid">29626210</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="mco270032-cit-0014">
<string-name>
<surname>Solomon</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lewthwaite</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Perera</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Cardosa</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>McMinn</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ooi</surname>
<given-names>MH</given-names>
</string-name>. <article-title>Virology, epidemiology, pathogenesis, and control of enterovirus 71</article-title>. <source>Lancet Infect Dis</source>. <year>2010</year>;<volume>10</volume>(<issue>11</issue>):<fpage>778</fpage>&#x02010;<lpage>790</lpage>.<pub-id pub-id-type="pmid">20961813</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="mco270032-cit-0015">
<string-name>
<surname>Plevka</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Perera</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cardosa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kuhn</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Rossmann</surname>
<given-names>MG</given-names>
</string-name>. <article-title>Crystal structure of human enterovirus 71</article-title>. <source>Science</source>. <year>2012</year>;<volume>336</volume>(<issue>6086</issue>):<fpage>1274</fpage>.<pub-id pub-id-type="pmid">22383808</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="mco270032-cit-0016">
<string-name>
<surname>Xia</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>GC</given-names>
</string-name>, et&#x000a0;al. <article-title>Human enterovirus nonstructural protein 2CATPase functions as both an RNA helicase and ATP&#x02010;independent RNA chaperone</article-title>. <source>PLoS Pathog</source>. <year>2015</year>;<volume>11</volume>(<issue>7</issue>):<elocation-id>e1005067</elocation-id>.<pub-id pub-id-type="pmid">26218680</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="mco270032-cit-0017">
<string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mueller</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Paul</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Wimmer</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>P</given-names>
</string-name>. <article-title>Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis</article-title>. <source>PLoS Pathog</source>. <year>2010</year>;<volume>6</volume>(<issue>8</issue>):<elocation-id>e1001066</elocation-id>.<pub-id pub-id-type="pmid">20865167</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="mco270032-cit-0018">
<string-name>
<surname>Xiao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Lei</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Enterovirus 3A facilitates viral replication by promoting phosphatidylinositol 4&#x02010;kinase IIIbeta&#x02010;ACBD3 interaction</article-title>. <source>J Virol</source>. <year>2017</year>;<volume>91</volume>(<issue>19</issue>):<fpage>e00791</fpage>&#x02010;<lpage>17</lpage>..<pub-id pub-id-type="pmid">28701404</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="mco270032-cit-0019">
<string-name>
<surname>Lei</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>. <article-title>Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll&#x02010;like receptor 3</article-title>. <source>J Virol</source>. <year>2011</year>;<volume>85</volume>(<issue>17</issue>):<fpage>8811</fpage>&#x02010;<lpage>8818</lpage>.<pub-id pub-id-type="pmid">21697485</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="mco270032-cit-0020">
<string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>TRAF3IP3 is cleaved by EV71 3C protease and exhibits antiviral activity</article-title>. <source>Front Microbiol</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>914971</elocation-id>.<pub-id pub-id-type="pmid">35814660</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="mco270032-cit-0021">
<string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Qiao</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Hao</surname>
<given-names>SB</given-names>
</string-name>, et&#x000a0;al. <article-title>Nonstructural protein 2A modulates replication and virulence of enterovirus 71</article-title>. <source>Virus Res</source>. <year>2018</year>;<volume>244</volume>:<fpage>262</fpage>&#x02010;<lpage>269</lpage>.<pub-id pub-id-type="pmid">29175108</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="mco270032-cit-0022">
<string-name>
<surname>Su</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Ho</surname>
<given-names>YF</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Hwang</surname>
<given-names>LH</given-names>
</string-name>. <article-title>Stimulation of the internal ribosome entry site (IRES)&#x02010;dependent translation of enterovirus 71 by DDX3X RNA helicase and viral 2A and 3C proteases</article-title>. <source>Front Microbiol</source>. <year>2018</year>;<volume>9</volume>:<fpage>1324</fpage>.<pub-id pub-id-type="pmid">29971060</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="mco270032-cit-0023">
<string-name>
<surname>Shih</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Stollar</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>ML</given-names>
</string-name>. <article-title>Host factors in enterovirus 71 replication</article-title>. <source>J Virol</source>. <year>2011</year>;<volume>85</volume>(<issue>19</issue>):<fpage>9658</fpage>&#x02010;<lpage>9666</lpage>.<pub-id pub-id-type="pmid">21715481</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="mco270032-cit-0024">
<string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>. <article-title>Dysregulated autophagy contributes to the pathogenesis of enterovirus A71 infection</article-title>. <source>Cell Biosci</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>142</fpage>.<pub-id pub-id-type="pmid">33298183</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="mco270032-cit-0025">
<string-name>
<surname>Huang</surname>
<given-names>PN</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Locker</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth</article-title>. <source>Nucleic Acids Res</source>. <year>2011</year>;<volume>39</volume>(<issue>22</issue>):<fpage>9633</fpage>&#x02010;<lpage>9648</lpage>.<pub-id pub-id-type="pmid">21880596</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="mco270032-cit-0026">
<string-name>
<surname>Fuentes</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Olguin</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Lopez&#x02010;Ulloa</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>Heterogeneous nuclear ribonucleoprotein K promotes cap&#x02010;independent translation initiation of retroviral mRNAs</article-title>. <source>Nucleic Acids Res</source>. <year>2024</year>;<volume>52</volume>(<issue>5</issue>):<fpage>2625</fpage>&#x02010;<lpage>2647</lpage>.<pub-id pub-id-type="pmid">38165048</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="mco270032-cit-0027">
<string-name>
<surname>Tolbert</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Morgan</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Pollum</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>HnRNP A1 alters the structure of a conserved enterovirus IRES domain to stimulate viral translation</article-title>. <source>J Mol Biol</source>. <year>2017</year>;<volume>429</volume>(<issue>19</issue>):<fpage>2841</fpage>&#x02010;<lpage>2858</lpage>.<pub-id pub-id-type="pmid">28625847</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="mco270032-cit-0028">
<string-name>
<surname>Lin</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Shih</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>hnRNP A1 interacts with the 5' untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication</article-title>. <source>J Virol</source>. <year>2009</year>;<volume>83</volume>(<issue>12</issue>):<fpage>6106</fpage>&#x02010;<lpage>6114</lpage>.<pub-id pub-id-type="pmid">19339352</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="mco270032-cit-0029">
<string-name>
<surname>Kaur</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lal</surname>
<given-names>SK</given-names>
</string-name>. <article-title>The multifarious roles of heterogeneous ribonucleoprotein A1 in viral infections</article-title>. <source>Rev Med Virol</source>. <year>2020</year>;<volume>30</volume>(<issue>2</issue>):<elocation-id>e2097</elocation-id>.<pub-id pub-id-type="pmid">31989716</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="mco270032-cit-0030">
<string-name>
<surname>Dan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Hsp27 responds to and facilitates enterovirus A71 replication by enhancing viral internal ribosome entry site&#x02010;mediated translation</article-title>. <source>J Virol</source>. <year>2019</year>;<volume>93</volume>(<issue>9</issue>):<fpage>e02322</fpage>&#x02010;<lpage>18</lpage>.<pub-id pub-id-type="pmid">30814282</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="mco270032-cit-0031">
<string-name>
<surname>Wu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Dan</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Targeting Ser78 phosphorylation of Hsp27 achieves potent antiviral effects against enterovirus A71 infection</article-title>. <source>Emerg Microbes Infect</source>. <year>2024</year>;<volume>13</volume>(<issue>1</issue>):<elocation-id>2368221</elocation-id>.<pub-id pub-id-type="pmid">38932432</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="mco270032-cit-0032">
<string-name>
<surname>Kostenko</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Moens</surname>
<given-names>U</given-names>
</string-name>. <article-title>Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology</article-title>. <source>Cell Mol Life Sci</source>. <year>2009</year>;<volume>66</volume>(<issue>20</issue>):<fpage>3289</fpage>&#x02010;<lpage>3307</lpage>.<pub-id pub-id-type="pmid">19593530</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="mco270032-cit-0033">
<string-name>
<surname>Henriques</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Koliaraki</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Kollias</surname>
<given-names>G</given-names>
</string-name>. <article-title>Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2018</year>;<volume>115</volume>(<issue>24</issue>):<fpage>E5546</fpage>&#x02010;<lpage>E5555</lpage>.<pub-id pub-id-type="pmid">29844172</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="mco270032-cit-0034">
<string-name>
<surname>Deng</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>WIP1 promotes cancer stem cell properties by inhibiting p38 MAPK in NSCLC</article-title>. <source>Signal Transduct Target Ther</source>. <year>2020</year>;<volume>5</volume>(<issue>1</issue>):<fpage>36</fpage>.<pub-id pub-id-type="pmid">32296033</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="mco270032-cit-0035">
<string-name>
<surname>Mellier</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bellot</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Holme</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Pervaiz</surname>
<given-names>S</given-names>
</string-name>. <article-title>Small molecule sensitization to TRAIL is mediated via nuclear localization, phosphorylation and inhibition of chaperone activity of Hsp27</article-title>. <source>Cell Death Dis</source>. <year>2013</year>;<volume>4</volume>(<issue>10</issue>):<elocation-id>e890</elocation-id>.<pub-id pub-id-type="pmid">24176848</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="mco270032-cit-0036">
<string-name>
<surname>Geum</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Son</surname>
<given-names>GH</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>K</given-names>
</string-name>. <article-title>Phosphorylation&#x02010;dependent cellular localization and thermoprotective role of heat shock protein 25 in hippocampal progenitor cells</article-title>. <source>J Biol Chem</source>. <year>2002</year>;<volume>277</volume>(<issue>22</issue>):<fpage>19913</fpage>&#x02010;<lpage>19921</lpage>.<pub-id pub-id-type="pmid">11912188</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="mco270032-cit-0037">
<string-name>
<surname>Lelj&#x02010;Garolla</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Mauk</surname>
<given-names>AG</given-names>
</string-name>. <article-title>Roles of the N&#x02010; and C&#x02010;terminal sequences in Hsp27 self&#x02010;association and chaperone activity</article-title>. <source>Protein Sci</source>. <year>2012</year>;<volume>21</volume>(<issue>1</issue>):<fpage>122</fpage>&#x02010;<lpage>133</lpage>.<pub-id pub-id-type="pmid">22057845</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="mco270032-cit-0038">
<string-name>
<surname>Selig</surname>
<given-names>EE</given-names>
</string-name>, <string-name>
<surname>Zlatic</surname>
<given-names>CO</given-names>
</string-name>, <string-name>
<surname>Cox</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>N&#x02010; and C&#x02010;terminal regions of alphaB&#x02010;crystallin and Hsp27 mediate inhibition of amyloid nucleation, fibril binding, and fibril disaggregation</article-title>. <source>J Biol Chem</source>. <year>2020</year>;<volume>295</volume>(<issue>29</issue>):<fpage>9838</fpage>&#x02010;<lpage>9854</lpage>.<pub-id pub-id-type="pmid">32417755</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="mco270032-cit-0039">
<string-name>
<surname>Hayes</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Napoli</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Mazurkie</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Stafford</surname>
<given-names>WF</given-names>
</string-name>, <string-name>
<surname>Graceffa</surname>
<given-names>P</given-names>
</string-name>. <article-title>Phosphorylation dependence of hsp27 multimeric size and molecular chaperone function</article-title>. <source>J Biol Chem</source>. <year>2009</year>;<volume>284</volume>(<issue>28</issue>):<fpage>18801</fpage>&#x02010;<lpage>18807</lpage>.<pub-id pub-id-type="pmid">19411251</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="mco270032-cit-0040">
<string-name>
<surname>Jovcevski</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Kelly</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Rote</surname>
<given-names>AP</given-names>
</string-name>, et&#x000a0;al. <article-title>Phosphomimics destabilize Hsp27 oligomeric assemblies and enhance chaperone activity</article-title>. <source>Chem Biol</source>. <year>2015</year>;<volume>22</volume>(<issue>2</issue>):<fpage>186</fpage>&#x02010;<lpage>195</lpage>.<pub-id pub-id-type="pmid">25699602</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="mco270032-cit-0041">
<string-name>
<surname>Clouser</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Baughman</surname>
<given-names>HE</given-names>
</string-name>, <string-name>
<surname>Basanta</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Guttman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nath</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Klevit</surname>
<given-names>RE</given-names>
</string-name>. <article-title>Interplay of disordered and ordered regions of a human small heat shock protein yields an ensemble of &#x02018;quasi&#x02010;ordered&#x02019; states</article-title>. <source>Elife</source>. <year>2019</year>;<volume>8</volume>:<elocation-id>e50259</elocation-id>.<pub-id pub-id-type="pmid">31573509</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="mco270032-cit-0042">
<string-name>
<surname>Nappi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Aguda</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Nakouzi</surname>
<given-names>NA</given-names>
</string-name>, et&#x000a0;al. <article-title>Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models</article-title>. <source>J Clin Invest</source>. <year>2020</year>;<volume>130</volume>(<issue>2</issue>):<fpage>699</fpage>&#x02010;<lpage>714</lpage>.<pub-id pub-id-type="pmid">31845908</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="mco270032-cit-0043">
<string-name>
<surname>Wendt</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lingitz</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Laggner</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Clinical relevance of elevated soluble ST2, HSP27 and 20S proteasome at hospital admission in patients with COVID&#x02010;19</article-title>. <source>Biology (Basel)</source>. <year>2021</year>;<volume>10</volume>(<issue>11</issue>):<fpage>1186</fpage>.<pub-id pub-id-type="pmid">34827178</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="mco270032-cit-0044">
<string-name>
<surname>Mathew</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Della Selva</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Burch</surname>
<given-names>AD</given-names>
</string-name>. <article-title>Modification and reorganization of the cytoprotective cellular chaperone Hsp27 during herpes simplex virus type 1 infection</article-title>. <source>J Virol</source>. <year>2009</year>;<volume>83</volume>(<issue>18</issue>):<fpage>9304</fpage>&#x02010;<lpage>9312</lpage>.<pub-id pub-id-type="pmid">19587060</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="mco270032-cit-0045">
<string-name>
<surname>Itzhaki</surname>
<given-names>RF</given-names>
</string-name>. <article-title>Corroboration of a major role for herpes simplex virus type 1 in Alzheimer's disease</article-title>. <source>Front Aging Neurosci</source>. <year>2018</year>;<volume>10</volume>:<fpage>324</fpage>.<pub-id pub-id-type="pmid">30405395</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="mco270032-cit-0046">
<string-name>
<surname>De Chiara</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Piacentini</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Fabiani</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Recurrent herpes simplex virus&#x02010;1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice</article-title>. <source>PLoS Pathog</source>. <year>2019</year>;<volume>15</volume>(<issue>3</issue>):<elocation-id>e1007617</elocation-id>.<pub-id pub-id-type="pmid">30870531</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="mco270032-cit-0047">
<string-name>
<surname>Fanning</surname>
<given-names>GC</given-names>
</string-name>, <string-name>
<surname>Zoulim</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Hou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bertoletti</surname>
<given-names>A</given-names>
</string-name>. <article-title>Therapeutic strategies for hepatitis B virus infection: towards a cure</article-title>. <source>Nat Rev Drug Discov</source>. <year>2019</year>;<volume>18</volume>(<issue>11</issue>):<fpage>827</fpage>&#x02010;<lpage>844</lpage>.<pub-id pub-id-type="pmid">31455905</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="mco270032-cit-0048">
<string-name>
<surname>Jeng</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Papatheodoridis</surname>
<given-names>GV</given-names>
</string-name>, <string-name>
<surname>Lok</surname>
<given-names>ASF</given-names>
</string-name>. <article-title>Hepatitis B</article-title>. <source>Lancet</source>. <year>2023</year>;<volume>401</volume>(<issue>10381</issue>):<fpage>1039</fpage>&#x02010;<lpage>1052</lpage>.<pub-id pub-id-type="pmid">36774930</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="mco270032-cit-0049">
<string-name>
<surname>Boora</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sharma</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Kaushik</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bhupatiraju</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kaushik</surname>
<given-names>S</given-names>
</string-name>. <article-title>Hepatitis B virus&#x02010;induced hepatocellular carcinoma: a persistent global problem</article-title>. <source>Braz J Microbiol</source>. <year>2023</year>;<volume>54</volume>(<issue>2</issue>):<fpage>679</fpage>&#x02010;<lpage>689</lpage>.<pub-id pub-id-type="pmid">37059940</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="mco270032-cit-0050">
<string-name>
<surname>Harimoto</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Shimada</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Aishima</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>The role of heat shock protein 27 expression in hepatocellular carcinoma in Japan: special reference to the difference between hepatitis B and C</article-title>. <source>Liver Int</source>. <year>2004</year>;<volume>24</volume>(<issue>4</issue>):<fpage>316</fpage>&#x02010;<lpage>321</lpage>.<pub-id pub-id-type="pmid">15287854</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="mco270032-cit-0051">
<string-name>
<surname>Wilhelm</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Carter</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lynch</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Discovery and development of sorafenib: a multikinase inhibitor for treating cancer</article-title>. <source>Nat Rev Drug Discov</source>. <year>2006</year>;<volume>5</volume>(<issue>10</issue>):<fpage>835</fpage>&#x02010;<lpage>844</lpage>.<pub-id pub-id-type="pmid">17016424</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="mco270032-cit-0052">
<string-name>
<surname>Garcia</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Rini</surname>
<given-names>BI</given-names>
</string-name>. <article-title>Recent progress in the management of advanced renal cell carcinoma</article-title>. <source>CA Cancer J Clin</source>. <year>2007</year>;<volume>57</volume>(<issue>2</issue>):<fpage>112</fpage>&#x02010;<lpage>125</lpage>.<pub-id pub-id-type="pmid">17392388</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="mco270032-cit-0053">
<string-name>
<surname>Gao</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Duan</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>The multi&#x02010;targeted kinase inhibitor sorafenib inhibits enterovirus 71 replication by regulating IRES&#x02010;dependent translation of viral proteins</article-title>. <source>Antiviral Res</source>. <year>2014</year>;<volume>106</volume>:<fpage>80</fpage>&#x02010;<lpage>85</lpage>.<pub-id pub-id-type="pmid">24680956</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="mco270032-cit-0054">
<string-name>
<surname>Holguin</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Hildenbrand</surname>
<given-names>ZL</given-names>
</string-name>, <string-name>
<surname>Bernal</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Insights into the role of heat shock protein 27 in the development of neurodegeneration</article-title>. <source>Front Mol Neurosci</source>. <year>2022</year>;<volume>15</volume>:<elocation-id>868089</elocation-id>.<pub-id pub-id-type="pmid">35431800</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="mco270032-cit-0055">
<string-name>
<surname>Alderson</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Roche</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gastall</surname>
<given-names>HY</given-names>
</string-name>, et&#x000a0;al. <article-title>Local unfolding of the HSP27 monomer regulates chaperone activity</article-title>. <source>Nat Commun</source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>1068</fpage>.<pub-id pub-id-type="pmid">30842409</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="mco270032-cit-0056">
<string-name>
<surname>Baranova</surname>
<given-names>EV</given-names>
</string-name>, <string-name>
<surname>Weeks</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Beelen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bukach</surname>
<given-names>OV</given-names>
</string-name>, <string-name>
<surname>Gusev</surname>
<given-names>NB</given-names>
</string-name>, <string-name>
<surname>Strelkov</surname>
<given-names>SV</given-names>
</string-name>. <article-title>Three&#x02010;dimensional structure of alpha&#x02010;crystallin domain dimers of human small heat shock proteins HSPB1 and HSPB6</article-title>. <source>J Mol Biol</source>. <year>2011</year>;<volume>411</volume>(<issue>1</issue>):<fpage>110</fpage>&#x02010;<lpage>122</lpage>.<pub-id pub-id-type="pmid">21641913</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="mco270032-cit-0057">
<string-name>
<surname>Pasta</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Raman</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ramakrishna</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Rao Ch</surname>
<given-names>M</given-names>
</string-name>. <article-title>The IXI/V motif in the C&#x02010;terminal extension of alpha&#x02010;crystallins: alternative interactions and oligomeric assemblies</article-title>. <source>Mol Vis</source>. <year>2004</year>;<volume>10</volume>:<fpage>655</fpage>&#x02010;<lpage>662</lpage>.<pub-id pub-id-type="pmid">15448619</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="mco270032-cit-0058">
<string-name>
<surname>Alderson</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Benesch</surname>
<given-names>JLP</given-names>
</string-name>, <string-name>
<surname>Baldwin</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Proline isomerization in the C&#x02010;terminal region of HSP27</article-title>. <source>Cell Stress Chaperones</source>. <year>2017</year>;<volume>22</volume>(<issue>4</issue>):<fpage>639</fpage>&#x02010;<lpage>651</lpage>.<pub-id pub-id-type="pmid">28547731</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="mco270032-cit-0059">
<string-name>
<surname>Theriault</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Lambert</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chavez&#x02010;Zobel</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Charest</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lavigne</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Landry</surname>
<given-names>J</given-names>
</string-name>. <article-title>Essential role of the NH2&#x02010;terminal WD/EPF motif in the phosphorylation&#x02010;activated protective function of mammalian Hsp27</article-title>. <source>J Biol Chem</source>. <year>2004</year>;<volume>279</volume>(<issue>22</issue>):<fpage>23463</fpage>&#x02010;<lpage>23471</lpage>.<pub-id pub-id-type="pmid">15033973</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="mco270032-cit-0060">
<string-name>
<surname>Ling</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Cellular Hsp27 interacts with classical swine fever virus NS5A protein and negatively regulates viral replication by the NF&#x02010;kappaB signaling pathway</article-title>. <source>Virology</source>. <year>2018</year>;<volume>518</volume>:<fpage>202</fpage>&#x02010;<lpage>209</lpage>.<pub-id pub-id-type="pmid">29525670</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="mco270032-cit-0061">
<string-name>
<surname>Bruey</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Ducasse</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bonniaud</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>Hsp27 negatively regulates cell death by interacting with cytochrome c</article-title>. <source>Nat Cell Biol</source>. <year>2000</year>;<volume>2</volume>(<issue>9</issue>):<fpage>645</fpage>&#x02010;<lpage>652</lpage>.<pub-id pub-id-type="pmid">10980706</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="mco270032-cit-0062">
<string-name>
<surname>Watters</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Palmenberg</surname>
<given-names>AC</given-names>
</string-name>. <article-title>Differential processing of nuclear pore complex proteins by rhinovirus 2A proteases from different species and serotypes</article-title>. <source>J Virol</source>. <year>2011</year>;<volume>85</volume>(<issue>20</issue>):<fpage>10874</fpage>&#x02010;<lpage>10883</lpage>.<pub-id pub-id-type="pmid">21835805</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="mco270032-cit-0063">
<string-name>
<surname>Watters</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Inankur</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Gardiner</surname>
<given-names>JC</given-names>
</string-name>, et&#x000a0;al. <article-title>Differential disruption of nucleocytoplasmic trafficking pathways by rhinovirus 2A proteases</article-title>. <source>J Virol</source>. <year>2017</year>;<volume>91</volume>(<issue>8</issue>):<fpage>e02472</fpage>&#x02010;<lpage>e02416</lpage>.<pub-id pub-id-type="pmid">28179529</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="mco270032-cit-0064">
<string-name>
<surname>Park</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Skern</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Gustin</surname>
<given-names>KE</given-names>
</string-name>. <article-title>Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease</article-title>. <source>J Biol Chem</source>. <year>2010</year>;<volume>285</volume>(<issue>37</issue>):<fpage>28796</fpage>&#x02010;<lpage>287805</lpage>.<pub-id pub-id-type="pmid">20622012</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="mco270032-cit-0065">
<string-name>
<surname>Park</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Schweers</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Gustin</surname>
<given-names>KE</given-names>
</string-name>. <article-title>Selective removal of FG repeat domains from the nuclear pore complex by enterovirus 2A(pro)</article-title>. <source>J Virol</source>. <year>2015</year>;<volume>89</volume>(<issue>21</issue>):<fpage>11069</fpage>&#x02010;<lpage>11079</lpage>.<pub-id pub-id-type="pmid">26311873</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="mco270032-cit-0066">
<string-name>
<surname>Walker</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Younessi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Fulcher</surname>
<given-names>AJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>8</issue>):<elocation-id>e71316</elocation-id>.<pub-id pub-id-type="pmid">23951130</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="mco270032-cit-0067">
<string-name>
<surname>Monette</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ajamian</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lopez&#x02010;Lastra</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mouland</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Human immunodeficiency virus type 1 (HIV&#x02010;1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: implications for HIV&#x02010;1 gene expression</article-title>. <source>J Biol Chem</source>. <year>2009</year>;<volume>284</volume>(<issue>45</issue>):<fpage>31350</fpage>&#x02010;<lpage>31362</lpage>.<pub-id pub-id-type="pmid">19737937</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="mco270032-cit-0068">
<string-name>
<surname>Yi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kung</surname>
<given-names>HF</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>ML</given-names>
</string-name>. <article-title>Potent inhibition of human enterovirus 71 replication by type I interferon subtypes</article-title>. <source>Antivir Ther</source>. <year>2011</year>;<volume>16</volume>(<issue>1</issue>):<fpage>51</fpage>&#x02010;<lpage>58</lpage>.<pub-id pub-id-type="pmid">21311108</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="mco270032-cit-0069">
<string-name>
<surname>Dong</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Men</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dan</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>Hsc70 regulates the IRES activity and serves as an antiviral target of enterovirus A71 infection</article-title>. <source>Antiviral Res</source>. <year>2018</year>;<volume>150</volume>:<fpage>39</fpage>&#x02010;<lpage>46</lpage>.<pub-id pub-id-type="pmid">29180285</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="mco270032-cit-0070">
<string-name>
<surname>Lu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1</article-title>. <source>J Virol</source>. <year>2012</year>;<volume>86</volume>(<issue>7</issue>):<fpage>3767</fpage>&#x02010;<lpage>3776</lpage>.<pub-id pub-id-type="pmid">22258259</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="mco270032-cit-0071">
<string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Inhibition of hepatitis B virus replication by stably expressed shRNA</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2003</year>;<volume>311</volume>(<issue>2</issue>):<fpage>398</fpage>&#x02010;<lpage>404</lpage>.<pub-id pub-id-type="pmid">14592428</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="mco270032-cit-0072">
<string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>Saikosaponin D suppresses enterovirus A71 infection by inhibiting autophagy</article-title>. <source>Signal Transduct Target Ther</source>. <year>2019</year>;<volume>4</volume>:<fpage>4</fpage>.<pub-id pub-id-type="pmid">30820356</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="mco270032-cit-0073">
<string-name>
<surname>Zhou</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>ML</given-names>
</string-name>. <article-title>Pim1 impacts enterovirus A71 replication and represents a potential target in antiviral therapy</article-title>. <source>iScience</source>. <year>2019</year>;<volume>19</volume>:<fpage>715</fpage>&#x02010;<lpage>727</lpage>.<pub-id pub-id-type="pmid">31476618</pub-id>
</mixed-citation></ref><ref id="mco270032-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="mco270032-cit-0074">
<string-name>
<surname>Ma</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer</article-title>. <source>Mol Cell Proteomics</source>. <year>2009</year>;<volume>8</volume>(<issue>8</issue>):<fpage>1878</fpage>&#x02010;<lpage>1890</lpage>.<pub-id pub-id-type="pmid">19460759</pub-id>
</mixed-citation></ref></ref-list></back></article>